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ABSTRACT OF THE DISSERTATION  
CONTRIBUTION OF LIPOPHILIC SECONDARY METABOLITES TO THE 
TOXICITY OF STRAINS OF FRESHWATER CYANOBACTERIAL HARMFUL 
ALGAL BLOOMS, IDENTIFIED USING THE ZEBRAFISH (DANIO RERIO) 
EMBRYO AS A MODEL FOR VERTEBRATE DEVELOPMENT 
by 
Asha Jaja-Chimedza 
Florida International University, 2014 
Miami, Florida 
Professor John Berry, Major Professor 
Cyanobacteria (blue-green algae) are known to produce a diverse repertoire of 
biologically active secondary metabolites. When associated with so-called harmful algal 
blooms, particularly in freshwater systems, a number of these metabolites have been 
associated - as toxins, or commonly cyanotoxins - with human and animal health 
concerns. In addition to the known water-soluble toxins from these genera (i.e. 
microcystins, cylindrospermopsin, and saxitoxins), our studies have shown that there are 
metabolites within the lipophilic extracts of these strains that inhibit vertebrate 
development in zebrafish embryos. Following these studies, the zebrafish embryo model 
was implemented in the bioassay-guided purification of four isolates of cyanobacterial 
harmful algal blooms, namely Aphanizomenon, two isolates of Cylindrospermopsis, and 
Microcystis, in order to identify and chemically characterize the bioactive lipophilic 
metabolites in these isolates.  
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We have recently isolated a group of polymethoxy-1-alkenes (PMAs), as potential 
toxins, based on the bioactivity observed in the zebrafish embryos. Although PMAs have 
been previously isolated from diverse cyanobacteria, they have not previously been 
associated with relevant toxicity. These compounds seem to be widespread across the 
different genera of cyanobacteria, and, according to our studies, suggested to be derived 
from the polyketide biosynthetic pathway which is a common synthetic route for 
cyanobacterial and other algal toxins. Thus, it can be argued that these metabolites are 
perhaps important contributors to the toxicity of cyanobacterial blooms. In addition to the 
PMAs, a set of bioactive glycosidic carotenoids were also isolated because of their 
inhibition of zebrafish embryonic development. These pigmented organic molecules are 
found in many photosynthetic organisms, including cyanobacteria, and they have been 
largely associated with the prevention of photooxidative damage. This is the first 
indication of these compounds as toxic metabolites and the hypothesized mode of action 
is via their biotransformation to retinoids, some of which are known to be teratogenic. 
Additional fractions within all four isolates have been shown to contain other 
uncharacterized lipophilic toxic metabolites. This apparent repertoire of lipophilic 
compounds may contribute to the toxicity of these cyanobacterial harmful algal blooms, 
which were previously attributed primarily to the presence of the known water-soluble 
toxins. 
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1.1. Cyanobacteria Harmful Algal Blooms 
Cyanobacteria, despite being commonly referred to as ‘blue-green algae’, are 
prokaryotic photosynthetic bacteria that are ubiquitous in nature with fossil records 
dating back more than 3 billion years being one of the oldest life forms on earth. 
Cyanobacteria are natural inhabitants of rocks, soil, and all water sources, where they can 
occur as free-living planktonic cells or form symbiotic phototrophic biofilm. The surface 
waters of both marine and freshwater systems, tends to host the growth of cyanobacteria 
whenever the conditions of light, temperature, and nutrients (nitrogen and phosphorus) 
are conducive, where they can aggregate to form visible masses known as “blooms”, 
primarily observed during the hot summer months. In addition to forming these “surface 
scum” in freshwater and brackish water reservoirs, cyanobacteria can also form “dense 
benthic mats” in marine and freshwater reservoirs. These blooms are then called “harmful 
algal blooms” (HAB; more specifically cyanoHABs) when they are associated with the 
production of toxic secondary metabolites which causes serious health problems in 
humans and animals (Paerl et al., 2011). 
Some of the most commonly occurring cyanobacterial blooms in freshwater 
sources belong to genera such as Anabaena, Aphanizomenon, Cylindrospermopsis, 
Nodularia, Microcystis, Plantothrix (Oscillatoria), and Plectonema (Lyngbya). These 
cyanoHABs produce many different toxins that cause various health effects ranging from 
mild skin irritations to more severe neurotoxicological effects and even death. Exposure 
routes to these toxins include swimming or other recreational activities in contaminated 
water sources, ingestion of contaminated drinking water, or consumption of foods in 
which there has been bioaccumulation of the toxins. As a result of the large amounts of 
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nutrients (nitrates and phosphates) being released into freshwater systems by various 
anthropogenic activities, there has been an increase in the eutrophication and 
hypertrophication of these systems. In addition, it is thought that with the changing of the 
global climate (increasing atmospheric CO2 and temperature) the conditions are more 
favorable to the growth and proliferation of these HABs (Paerl et al., 2011). As such 
these cyanoHABs are a major environmental and health problem around the world, 
particularly because of the production of various toxins including the known commonly 
studied toxins and those toxins which still remain unknown. 
 
1.2. Cyanobacterial Secondary Metabolites (or Cyanobacterial Toxins) 
As a result of the long evolutionary history of cyanobacteria, they have developed 
morphological, physiological, and ecological adaptability to geochemical and ecological 
changes in their environment. Cyanobacteria produce various types of secondary 
metabolites (usually genera-, species-, and strain-specific) which allow them to persist 
under harsh conditions such as high herbivory and extreme nutrient and light conditions 
(Yadav et al., 2011). These secondary metabolites can be classified into groups according 
to the functions of the compounds, having both positive and negative effects, such as 
antiviral compounds, grazer/feeding deterrents, antimicrobial compounds, anticancer 
compounds, protease inhibitors, photoprotective compounds, and cyanotoxic compounds 
(Yadav et al., 2011). Cyanobacterial toxins are referred to as such because of the negative 
health effects that are associated with their exposure to humans and animals. 
Table 1.1 provides a list of the various known cyanobacterial toxins according to 
their chemical composition and also includes their toxicological classification, and the 
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genera from which they are produced. The toxicological classification is also included for 
each of the cyanotoxins based on their action on principal target organs and includes 
hepatotoxins, neurotoxins, dermatotoxins, and endotoxins. Even though these toxins 
might have the same target organ, they are structurally different and as such have 
different mechanism of action with some toxins producing the similar effects (e.g., 
neurotoxins causing respiratory paralysis). 
 5 
 
Table 1. 1:  Cyanobacterial Toxins, Their Toxicological Classification, Toxin Producing Genera, and Mode of Action 
Class of Cmpds Toxin/Toxin Group T.C.  Toxin-producing genera Mode of Action 
Cyclic Peptides Microcystins Hepatotoxins Microcystis, Anabaena, 
Oscillatoria, Nostoc, 
Anabaenopsis, Planktothrix, others
Inhibits serine/threonine 
protein phosphatases 1 and 2A
 Nodularins Hepatotoxins Nodularia Inhibits serine/threonine 
protein phosphatases 1 and 2A
Alkaloids Anatoxin-a, 
Homoanatoxin-a 
Neurotoxins Anabaena, Aphanizomenon, 
Oscillatoria, Microcystis, 
Phormidium, Cylindrospermum, 
Raphidiopsis,  
Neuromuscular blocking 
agent 
 Anatoxin-a(s) Neurotoxins Anabaena Inhibits neurotransmission 
 Saxitoxins Neurotoxins Aphanizomenon, Anabaena, 
Lyngbya, Cylindrospermopsis 
Blocks sodium channels in 
nerve cells 
 Cylindrospermopsin Hepatotoxins Anabaena, Aphanizomenon, 
Cylindrospermopsis, Raphidiopsis 
Inhibits protein synthesis 
 Lyngbyatoxin 
 
 
Dermatoxin Lyngbya Inflammatory and tumor 
promoting via activation of 
protein kinase C 
 Aplysiatoxin Dermatoxin Lyngbya, Oscillatoria Activation of protein kinase C 
Others β-methylamino-ʟ-
alanine (BMAA) 
Neurotoxins 
 
Nostoc, Fischerella, Symploca, 
Synechococcus, Trichodesmium 
and many others 
Glutamate receptor agonist, 
induction of oxidative stress, 
and other unknown 
mechanisms 
 Lipopolysaccharides Endotoxins Microcystis, Oscillatoria Stimulation of inflammatory 
responses 
Note: Updated from Codd et al, 1999; Stewart et al, 2006.  
T.C. – toxicological classification 
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1.2.1. Hepatotoxic Cyclic Peptides 
Microcystin (MCYST) is one of the most commonly studied cyanotoxins and is a 
part of a family of cyclic heptapeptides with over 70 different variants currently isolated 
from various cyanobacterial strains (Yadav et al., 2011). These variants of MCYST are 
usually seen by the different amino acids at the R1 and R2 positions (Figure 1.1), with the 
most commonly isolated MCSYTs being microcystin-LR, -RR, and -YR in the R1 and R2 
positions respectively, where L is leucine, R is arginine, and Y is tyrosine (Izaguirre et 
al., 2007, Jungblut & Neilan, 2006). Microcystin was first isolated from the freshwater 
cyanobacterium Microcystis aeruginosa and has subsequently been isolated from other 
cyanobacterial genera including Anabaena, Oscillatoria, Nostoc, Anabaenopsis, 
Planktothrix, and others (Prieto et al., 2006; Izaguirre et al., 2007; Sangolkar et al., 2006; 
Carmichael, 1992). 
Microcystins are potently toxic, and exposure to these toxins has been associated 
with animal and human poisoning, and in severe cases, has led to death in vertebrate 
animals and humans (Wiegand et al., 2005). They are known to cause liver damage 
through the inhibition of type 1 and 2A serine/threonine protein phosphatases, which 
leads to excessive phosphorylation of cytoskeleton filaments (Dai et al., 2007). They also 
promote the growth of tumors in the liver and colon, and can produce allergic and 
gastrointestinal reactions through long term exposure to low levels (Dai et al., 2007).  
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Figure 1. 1: General structure of microcystin showing the variable R-groups (R1, R2). 
 
Nodularins (NOD) are another class of nonribosomal hepatotoxic cyclic peptides 
that are similar in structure to that of microcystins with less structural variation within the 
family, and slightly higher water solubility (Figure 1.2). Nodularin is produced by the 
cyanobacterium, Nodularia spumigena, which is commonly found as blooms in the 
brackish waters of the Baltic Sea. Nodularins are closetly related to MCYSTs (possessing 
the same Adda moiety) and also act by inhibiting the serine/threonine protein 
phosphatases type 1 and type 2A (Ohta et al., 1994, Pflugmacher et al., 1998). Nodularin 
producing N. spumigena has been linked to deaths of both domestic and wild animals in 
regions such as Australia, New Zealand, and the Baltic Sea (Moffitt and Neilan 2004). 
 
Figure 1. 2: Structure of nodularin 
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1.2.2. Neurotoxic Alkaloids 
Anatoxin-a (ATX) along with its methylene homologue, homoanatoxin-a (Figure 
1.3) are neurotoxic alkaloids that are commonly found in the cyanobacterial genera, 
Anabaena and Oscillatoria and have been frequently implicated in the poisoning of birds 
and mammals (Stewart et al., 2008). Anatoxin-a is a potent nicotinic agonist for the 
acetylcholine receptor, acting as a postsynaptic, depolarizing, neuromuscular blocking 
agent (James et al., 1997). Exposure to ATX can cause paralysis of the peripheral skeletal 
and respiratory muscles, tremors, convulsions, and death (Rogers et al., 2005). 
 
 
Figure 1. 3: Structure of anatoxin-a (left) and homoanatoxin-a (right) 
 
Anatoxin-a(s) (ATS), (s) for salivation, is a naturally occurring organophosphate 
that is associated with the cyanobacteria Anabaena flos-aquae. Despite its name, ATS is 
a phosphate ester of a cyclic N-hydroxyguanidine and is therefore unrelated to ATX 
(Figure 1.4). The neurotoxic effects associated with ATS are caused by the irreversible 
inhibition of acetylcholinesterase, preventing neurotransmission (Devic et al., 2002). The 
symptoms associated with this toxin include hypersalivation, ataxia, diarrhea, tremors, 
dyspnea, and cyanosis. It is also responsible for the intoxication of domestic animals 
(Dittmann and Wiegand, 2006). 
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Figure 1. 4: Structure of anatoxin-a(s) 
 
Saxitoxin (STX) is a water-soluble neurotoxic alkaloid (Figure 1.5) that along with 
its analogues, are classified as paralytic shellfish toxins (PSTs) as a result of their 
involvement in paralytic shellfish poisoning (PSP). There are currently over 20 structural 
variants of the toxin and they are classified as non-sulfated, singly-sulfated, doubly 
sulfated, and decarbamoylated, and possessing varying degrees of toxicity. Saxitoxins 
can be found in both marine (produced by dinoflagellates) and freshwaters (produced by 
cyanobacteria) being produced by organisms belonging to two different kingdoms. In 
freshwater, STXs have been isolated from the cyanobacteria Cylindrosermopsis, 
Anabaena, Aphanizomenon, Lyngbya, and Plantothrix and in marine environments from 
the dinoflagellates Alexandrium, Gymnodinium and Pyrodinium (Dittman et al., 2013; 
Lefebvre et al., 2004). Saxitoxins exhibit their toxicity by reversibly binding to voltage-
gated sodium channels resulting in neurotoxic effects including nausea, numbness, ataxia, 
and paralysis which can lead to death as a result of respiratory failure (Lefebvre et al., 
2004). 
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Figure 1. 5: Structure of saxitoxin 
 
1.2.3. Cytotoxic Alkaloids 
Cylindrospermopsin (CYN) is characterized as a hepatotoxic, water-soluble cyclic 
guanidinium alkaloid which also causes general cytotoxic and neurotoxic effects (Figure 
1.6; Ohtani et al., 1992). Cylindrospermopsin was originally isolated from the 
cyanobacterium belonging to the genera Cylindrospermopsis but subsequently found in 
other freshwater cyanobacterial genera such as Anabaena, Aphanizomenon, Lyngbya, 
Raphidiopsis, and Umezakia (Harada et al., 1994; Banker et al., 1997; Li et al., 2001; 
Seifert et al., 2007). Predominantly, occurrence of CYN has been reported in the tropical 
and subtropical regions in water reservoirs such as lakes, rivers, and ponds; however 
reports have indicated their presence in more temperate environments (Neilan et al., 
2003; Fastner et al., 2007).  
The toxicity of CYN was originally determined because of an outbreak of 
symptoms of gastroenteritis among more than 100 children from an Aboriginal 
community on Palm Island in Queensland, Australia. The cause of the illness was 
subsequently linked to a contaminated water supply (Solomon Dam) containing a dense 
algal bloom, which contained a strain of C. raciborskii. Even though CYN has been 
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termed a hepatotoxin as a result of its main in vivo effect, it has been shown to target 
other organs including the lungs, heart, kidneys, adrenal glands, and others (López-
Alonso et al., 2013). Considerable efforts have been made to identify the specific toxicity 
of CYN however these effects are still unclear. The toxicity of CYN is thought to be 
associated with the inhibition of protein synthesis and glutathione production (Runnegar 
et al., 2002; Humpage et al., 2005). 
 
Figure 1. 6: Structure of cylindrospermopsin 
 
1.2.4. Dermatotoxic Alkaloids 
Lyngbyatoxin-a (LTX) is an indole-containing alkaloid, produced by the marine 
cyanobacterium Lyngbya majuscula which is typically found in coastal and estuarine 
waters of tropical and subtropical environments (Fiure 1.7; Dittman et al., 2013) 
Lyngbyatoxin is a highly potent skin irritant that is known to cause the condition, 
Swimmer’s Itch, by specific activation of protein kinase C (PKC). Human exposure with 
the cyanobacteria causes the development of erythema and blisters and has also been 
found to be highly toxic to fish and other grazer species (Cardellina et al., 1979). 
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Figure 1. 7: Structure of lyngbyatoxin 
 
Aplysiatoxin (APX) (and debromoaplysiatoxin) are phenolic bislactones that along 
with LTX are thought to be the cause of contact dermatitis associated with L. majuscula 
(Figure 1.8; Moore et al., 1984). In addition to cyanobacteria, APXs have also been 
detected in the red alga Gracularia coronopifolia (Ito & Nagai, 1998). Toxicity of APX also 
occurs through ingestion and causes symptoms such as vomiting, diarrhea, and bleeding in 
the small intestine with the suggested mode of action being an activator of protein kinase C 
(Ito and Nagai, 2000). 
 
Figure 1. 8: Structure of aplysiatoxin 
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1.2.5. Other Cyanobacterial Toxins 
β-methylamino-ʟ-alanine (BMAA) is a non-proteinogenic amino acid (Figure 1.9) 
that was originally isolated from cycads and subsequently isolated from an endophytic 
cyanobacterium (genus Nostoc) that resided in the specialized roots of the Guam cycad 
plants (Banack et al., 2007). It has since been found in other taxonomic groups of 
cyanobacteria, both free-living and bloom forming strains. The amino acid is thought to 
be associated with neurodegenerative diseases such as dementia and amyotrophic lateral 
sclerosis (ALS) however further research is essential to identifying its mode of action and 
health risks from environmental exposure (Chiu et al., 2011; Okle et al., 2013).    
The mechanism of action of BMAA is still being investigated however there are 
studies that have indicated that it acts as a glutamate receptor agonist, such as NMDA, 
AMPA, ionotropic and metabotropic glutamate receptors. It has also been suggest to 
increasing oxidative stress by the inhibition of the cysteine/glutamate antiporter system 
which prevents the uptake of cysteine thereby causing depletion in glutathione (Chiu et 
al., 2011). Continued research is being done to get a better understanding of the mode of 
action of this neurotoxin and how it relates to neurodegeneration. 
 
Figure 1. 9: Structure of BMAA 
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Lipopolysaccharides (LPS) are characteristic structural components of the outer 
membrane of Gram-negative bacteria, including cyanobacteria. The structure of LPS is 
comprised of four segments covalently linked: lipid A moiety (acylated glycolipid), a 
core oligosaccharide (made up of an inner and outer segment) and an O-specific chain 
(carbohydrate polymer on the surface). Cyanobacterial LPSs are thought to be different, 
both in structure and function, from Gram-negative bacteria, where one study showed 
that cyanobacterial LPSs lacks significant endotoxin activity due to the structural 
differences in the lipid A moiety (Stewart et al., 2006). There are limited studies on LPS 
as cyanobacterial toxins; however some studies have shown that health effects associated 
with these LPSs have a wide range and can include gastro-intestinal illness, skin rashes, 
allergy, respiratory disease, headache, fever, and other health incidents (Stewart et al., 
2006). 
 
1.3. Biosynthetic Pathways of Cyanobacterial Secondary Metabolites 
The structures of majority of the cyanobacterial secondary metabolites are peptides, 
peptide-like structures or polyketides. The common biosynthetic pathways associated 
with the production of cyanobacterial secondary metabolites are the non-ribosomal 
peptide synthetase (NRPS) for the peptidic structures, and polyketide synthase (PKS) 
pathways for the polyketide structures. There is also a hybrid NRPS/PKS pathway that is 
also involved in the production of the peptidic metabolites (Dittman et al., 2013).  
Secondary metabolites that have cyclic or branched-cyclic structures, or small 
peptides with unusual or modified amino acids typically indicated the involvement of a 
non-ribosomal biosynthetic pathway. The NRPS biosynthetic pathway can be standalone 
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or can occur in hybrid enzyme complexes, often with the PKS pathway as a result of the 
structural and mechanistic similarities of the biosynthetic pathway. Non-ribosomal 
peptide synthetases are made up of large modular, multi-enzyme complex, in which each 
module has a role in different stages of the synthesis such as activation, thiolation, 
modification, and condensation of an amino acid substrate. The organization and order of 
the NRPS modules within the complex follows the co-linearity rule where it corresponds 
with that of the amino acid sequence within the peptide product (Dittman et al., 2001).  
The other biosynthetic pathway that is commonly observed in cyanobacteria is the 
PKS pathway which, similar to NRPS, involves a family of modular enzymes which are 
organized as functional units. Each PKS unit catalyzes specific reactions in the 
elongation of the polyketide chain with each unit comprising of at least a ketosynthase 
(KS), acyl transferase (AT) and acyl carrier protein (ACP) domain. The carbon backbone 
of the polyketides is biosynthesized by decarboxylative condensation of acyl coenzyme A 
(Acyl-CoA) subunits, typically using acetate as building blocks. Further modification to 
the backbone can then be made by various subsequent enzyme “modules” (e.g., 
ketoreductases (KR), dehydrogenases (DH)) into the final biosynthetic product (Snyder et 
al., 2003). 
 
1.3.1. Non-Ribosomal Peptide Synthetase/Polyketide Synthase (NRPS/PKS) 
Most of the biosynthetic pathways involved in cyanobacterial toxin production 
seem to involve a hybrid NRPS/PKS pathway, including the well-studied hepatotoxic 
cyclic peptide MCYST and its related pentapeptide NOD, the hepatotoxic alkaloid CYN, 
and the neurotoxic alkaloid, ATX. The biosynthetic route for the cyclic peptides 
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(MCYST and NOD) was thought to be similar and feeding experiments as well as their 
unusual structure suggested that biosynthesis was of non-ribosomal origin (Moore et al., 
1991).  
The MCYST biosynthetic gene cluster (mcyS) is 55kb and comprises of ten genes 
(McyA-J) with two bidirectional operons (mcyA-C and mcyD-J). The larger operon 
(mcyD-J) encodes for two NRPS/PKS hybrid (McyE and G) modules and a PKS (McyD) 
modules involved in the formation of the Adda moiety. This operon also encodes for 
enzymes involved in the modification (McyF, J, and I) and transport (McyH) of MCYST. 
Operon mcyA-C encodes for three NRPS modules (McyA-C) which is involved in the 
extension to the heptapeptide as well as subsequent cyclization (Tillett et al., 2000 and 
Pearson et al., 2010). The course of reactions for MCYST biosynthesis is the same across 
different genera of cyanobacteria with some variation in domain specificities (Dittman et 
al., 2013). The proposed biosynthetic pathway for NOD is similar to that of MCYST and 
the assignments of the enzymes were made on the basis of the homology with the 
MCYST enzymes combined with bioinformatics analysis. The NOD gene cluster (ndaS) 
is 48kb and consisting of nine open reading frames (ORFs; ndaA-I) and are also 
assembled with a bidirectional operon. The mixed NRPS/PKS (NdaC, D, and F) modules 
are involved in the formation of the Adda side chain and the two NRPS (NdaA and B) 
modules are involved in adding the other amino acids for completion of the cyclic 
pentapeptide (Pearson et al., 2010; Dittman et al., 2013). 
The putative biosynthesis genes for CYN were identified in A. ovalisporum, with 
the gene products involved being an amidinotransferase (AoaA), a NRPS/PKS hybrid 
(AoaB), and a PKS (AoaC) along with other unidentified enzymes (Shalev-Alon et al., 
 17 
 
2002). The complete CYN biosynthesis gene cluster from C. raciborskii (cyr) was 
subsequently revealed by genome walking to be 43kb and encodes for 15 ORFs and 
includes all the necessary functions for the biosynthesis, regulation, and transport of the 
toxin. The corresponding homologs of AoaA, B, and C are CyrA, B, and C respectively. 
The first step in the biosynthesis involves the formation of the guanidinoacetate catalyzed 
by CyrA followed by activation via CyrB is thought to be involved in the second step. 
Subsequent steps involve the elongation and modifications by PKS modules (CyrC, D, E, 
and F). The ring formations are thought to occur spontaneously, leaving the other gene 
products for the final biosynthesis, tailoring and transport of the toxin (Mihali et al., 
2008). 
Biosynthesis of ATX was thought to involve the PKS pathway as a result of 
feeding experiments that indicated that the carbon skeleton was derived from acetate and 
glutatmate (Hemcheidt et al., 1995). The ATX biosysnthesis gene cluster (ana) encodes 
for seven proteins (AnaA-G) with the proposed biosynthetic route being in two stages. 
The first stage in the biosynthesis begins with proline as the starter unit activated by 
AnaC (a NRPS-type adenylation protein) then subsequently loaded on AnaD (an ACP). 
The second stage then involves elongation, cyclization, and modification on the PKS 
(AnaE, F, and G) modules. This proposed biosynthetic route was suggested based on 
feeding experiments and bioinformatics analysis (Mejean et al., 2010; Mann et al., 2011). 
 
1.3.2. Non-ribosomal Peptide Synthetase 
The LTX biosynthesis gene cluster (ltx) consists of four genes (ltxA-D) making it 
the smallest cluster identified in the known cyanobacterial toxin biosynthesis. Feeding 
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studies of teleocidin (a closely related toxin in Streptomyces sp.) helped to identify LTX 
biosynthesis, revealing the incorporation of L-valine and L-tryptophan into the 
indolactam ring. The proposed structure involves the condensation of N-methyl-L-Val 
and L-Trp by LtxA (NRPS) followed by its release by reductive cleavage. LtxB (a 
cytochrome P450 monooxygenase) is involved with the formation of the indolactam ring 
with LtxC (phetnytransferase) involved in the generating the quaternary carbon by adding 
a geranyl group to the indolactam core (Huynh et al., 2010).  
 
1.3.3. Other Biosynthetic Pathways 
The biosynthetic route for STX does not follow the typical NRPS or PKS pathway. 
Radioisotope feeding experiments suggested that arginine, acetate, and methionine 
methyl were involved in the biosynthesis with subsequent confirmation using a reverse 
genetics approach (Kellmann & Neilan, 2007). The STX gene cluster (stx) was first 
identified in C. raciborskii as a 35kb gene locus with homologous clusters being found in 
other genera ranging in size from 25.7-36 kb. The toxin profile expressed by these 
clusters depends on the presence and the organization of the stx genes. The initiation of 
STX biosynthesis is thought to involve the methylation of acetate and a Claisen 
condensation reaction with arginine by an unusual PKS-like enzyme, StxA. Subsequent 
reactions include three heterocyclizations and tailoring reactions, which give rise to 
different isoforms of the toxin (Kellmann et al., 2008).  
The biosynthetic pathways for the neurotoxic, BMAA and the dermatotoxin, APX 
have yet to be elucidated. 
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1.4. Zebrafish Embryo Model 
Zebrafish (Danio rerio) are small freshwater fish that have been an integral part of 
laboratory studies for the past few decades especially as it relates to the effects of various 
chemicals on developmental processes and identifying the cellular and molecular 
mechanisms involved. There are many attributes of the zebrafish that makes its use 
suitable as a developmental model such as their small size, ease of husbandry, high 
fecundity, transparent chorion, and rapid embryonic development. Zebrafish mating and 
breeding can occur almost all year round producing a large number of eggs (hundreds and 
sometimes thousands) with one breeding. The embryos are very small (about 1mm in 
diameter) and at 7 days post fertilization (dpf) can grow up to about 4 mm in length 
which allows for the use of multiple embryos with each exposure and use in high-
throughput exposures, using minimal amounts of toxicant. Additionally, embryos can 
survive on its yolk for up to 7dpf, so exposure studies can be done without the 
complication of added food. The embryos develop in a transparent chorion making the 
examination and monitoring of the developmental features easily achieved using a 
dissecting light-microscope. Zebrafish undergo rapid embryonic development (See 
Figure 1.10) with most of the internal organs being fully developed by 96 hours post 
fertilization (hpf), which therefore produces a quick response with exposure studies. Even 
though zebrafish are not the only teleost fish that possess these characteristics, the added 
advantage to using the zebrafish above these other teleost fish lies in the completely 
elucidation of the genome which allows them to be used for additional studies, including 
genetic studies. 
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Figure 1. 10: Stages of development of the zebrafish embryo taken using an Olympus camera 
attached to a dissecting microscope: A - Newly fertilized embryo, B - 1dpf, C - 2dpf, D – 3dpf, E 
- newly hatched embryo. 
 
The zebrafish has been implemented as a model for various studies as a result of 
their applicable attributes to different areas of study. One of these has been the use of 
zebrafish as a model of vertebrate development (Oberemm et al., 1997; Papendorf et al., 
1997; Veldman et al., 2008). It has also been an ideal genetic system for the study of 
developmental and human disease (Dodd et al., 2000; Zhu & Zon, 2002), including 
neurological diseases (Best et al., 2008) and developmental neurotoxicology (Linney et 
al., 2004). More recently, the zebrafish has been used for drug screening and discovery, 
especially in the area of cardiovascular drug discovery (Rocke et al., 2009). The zebrafish 
model has also been used for toxicological studies of various natural occurring toxins, 
specifically in the identification and characterization of developmental toxins from 
marine dinoflagellates and cyanobacteria (Berry et al., 2007) as well as the toxic effects 
of cylindrospermopsin (Berry et al., 2009).  They have also been used to study selected 
detoxifying enzymes in response to various toxins, such as microcystin (Wiegand et al., 
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1999), lipopolysaccharides in conjunction with microcystin (Best et al., 2002), and 
natural organic matter on microcystin toxicity (Cazenave et al., 2006). 
 
1.4.1. As a model for vertebrate development and toxicological studies 
Much research has been carried out using the zebrafish as a model for toxicological 
studies of various natural occurring toxins. The zebrafish embryo model has been 
previously used in the study of several of the known toxins from cyanobacteria (e.g. 
Lefebvre et al., 2004; Wang et al., 2005; Berry et al., 2009). Wang et al. (2005) carried 
out a study to analyze the effects of microcystin on zebrafish embryos. During the study, 
it was observed that microcystin was not taken up by the embryo, and as such 
microinjections of embryos were required, after which the effects of the toxin became 
apparent. A similar study was done with cylindrospermopsin, showing that 
microinjection was also required in order to observe the effects of the toxin (Berry et al., 
2009). Even though these toxins are water-soluble in nature, there seems to be some 
prevention in the uptake of these toxins in the embryo. Within the same study, Berry et 
al. (2009) tested the lipophilic extracts of eight different isolates of cyanobacteria, 
including cylindrospermopsin-producing C. raciborskii and A. ovalisporum and non-
cylindrospermopsin producing C. raciborskii, and showed that there were developmental 
effects on the zebrafish embryos. These studies showed that the compounds responsible 
for the bioactivity were unrelated to the known toxins from those strains of 
cyanobacteria, which is evident because of the apparent lipophilic nature of the bioactive 
extract, and as bioactivity was seen in non-cylindrospermopsin producing strains of 
cyanobacteria. 
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1.4.2. Bioassay-guided fractionations using zebrafish embryos 
The zebrafish embryo has been previously used in the bioassay-guided 
fractionations of bioactive metabolites from various sources as a model for vertebrate 
development as it relates to inhibition of development and as a model for natural product 
discovery (Crawford et al., 2011; Liu et al., 2011; Han et al., 2012) as it relates to 
inhibition of angiogenesis. This model has also been implemented in the screening of 
small molecules for the discovery of cardiovascular drugs (Novodvorsky et al., 2013).  
 
 
1.5. Research Objectives 
Cyanobacteria are known to produce a diverse repertoire of biologically active 
secondary metabolites. When associated with so-called “harmful algal blooms”, 
particularly in freshwater systems, a number of these metabolites have been associated - 
as “toxins”, or commonly “cyanotoxins” - with human and animal health concerns 
(Valério et al., 2010; Carmichael, 2008; Ferrão-Filho and Kozlowsky-Suzuki, 2011). It is 
notable, although perhaps not surprising, that all of these recognized toxins are generally 
polar and water-soluble metabolites. Previous studies have identified the presence of 
uncharacterized toxic lipophilic metabolites in toxic and non-toxic strains of cyanoHABs 
which may give rise to the toxigenicity of the species (e.g. Falch et al., 1995; Nogueira et 
al., 2006; Berry et al., 2009).  
Recently, Berry et al. (2009) showed that lipophilic extracts (not containing CYN 
or STX) from C. raciborskii and A. ovalisporum inhibit the development of zebrafish 
embryos. Additionally, a screening was done with the lipophilic extracts of other 
cyanobacterial isolates, including a few cyanoHABs, which also showed the bioactivity 
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of the previously identified isolates as well as bioactivity with other cyanobacterial 
isolates (Table 1.1). Over thirty (30) isolates of cyanobacteria and green algae were 
obtained and the lipophilic extracts were screened at a representative low and high 
dosage for bioactivity using the zebrafish embryo bioassay. The extracts from ten isolates 
of cyanobacteria and green algae showed mortality and inhibition of development at sub-
lethal dosages up to 5dpf (Table 1.1). The lipophilic extracts from the cyanobacteria 
isolates that showed bioactivity were Aphanothece 80-12a, Pseudanabaena 108-1, 
Microcystis 81-11, Aphanizomenon APH, and two isolates of C. raciborskii 121-1 and 
AQS, four of which belong to genera that are considered cyanoHABs.  The lipophilic 
extracts from the green algae that showed bioactivity were Chlamydomonas 80-1, 
Kirchneriella 104-7, and two different isolates of Scenedesmus 79-1 and 80-15. 
 
Table 1. 2: Cyanobacteria and green algae chloroform extracts that were used in the screening 
against the zebrafish embryos, indicating the ones that showed bioactivity by inhibiting their 
development. 
Isolates Chloroform Extracts / µL 
 10 100 
Cyanobacteria   
Aphanothece 103-7  X 
Aphanizomenon APH  X X 
C. raciborskii 121-1 X X 
C. raciborskii AQS  X X 
Microcystis 81-11 X X 
Pseudanabaena 108-1 X X 
Green Algae   
Chlamydomonas 80-1 X X 
Kirchneriella 104-7 X X 
Scenedesmus 79-1 X X 
Scenedesmus 80-15  X 
Note: Isolates in bold are from genera that are considered cyanoHABs. 
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1.5.1. Specific Aims 
In continuity to these preliminary findings, the current study was developed to 
focus on the identification of these lipophilic bioactive metabolites that contribute to the 
toxicity of these cyanoHABs. The study therefore implemented the use of the zebrafish 
embryo bioassay as a model for vertebrate development to guide the isolation of these 
compounds for subsequent characterization of these ‘toxic’ lipophilic metabolites. As 
such, the specific aims were as follows:  
a) Isolate and characterize bioactive compounds within the lipophilic extract of known 
toxigenic strains of freshwater cyanobacteria, namely Microcystis spp., 
Cylindrospermopsis raciborskii, and Aphanizomenon ovalisporum. The collection 
sites for the isolates are indicated in the table below. 
Table 1. 3: Cyanobacterial isolates used in this study and their sources of origin. 
Cyanobacterial Isolate Source of Origin 
A. ovalisporum Lake Kinneret, Israel 
C. raciborskii 121-1 Catemaco, Mexico 
C. raciborskii AQS Townsville, Australia 
M. aeruginosa 81-11 Bay of Quinte, Lake Ontario 
 
b) Develop an analytical method to effectively identify and quantify the bioactive 
compounds and evaluate the occurrence, and possible bioaccumulation, of these 
compounds in freshwater sources. 
i. A modification to this objective was to evaluate the occurrence of the bioactive 
compounds in different genera and species of cyanobacteria, since locating 
freshwater sources known to have these identified and characterized bioactive 
compounds would be difficult. 
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ii. An addition to this objective involved doing feeding experiments with 13C-labeled 
acetate to test the hypothesis that biosynthesis of the polymethoxy-1-alkenes 
(PMAs) is via the polyketide biosynthetic pathway. 
c) Toxicological characterization of the purified compounds was focused on the 
developmental defects of the zebrafish including mortality, hatching rates, and 
inhibition of development.  
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CHAPTER 2* 
 
POLYMETHOXY-1-ALKENES FROM APHANIZOMENON OVALISPORUM AND 
CYLINDROSPERMOPSIS RACIBORSKII INHIBIT VERTEBRATE DEVELOPMENT 
IN ZEBRAFISH (DANIO RERIO) EMBRYOS 
 
(*This chapter has been modified from Jaja-Chimedza et al., 2012, Marine Drugs.)
 34 
 
2.1. Introduction 
Cyanobacteria (“blue-green algae”) are known to produce a diverse repertoire of 
biologically active secondary metabolites (Valério et al., 2010). When associated with so-
called “harmful algal blooms”, particularly in freshwater systems, a number of these 
metabolites have been associated - as “toxins”, or commonly “cyanotoxins” - with human 
and animal health concerns (Valério et al., 2010; Carmichael, 2008; Ferrão-Filho and 
Kozlowsky-Suzuki, 2011). As health concerns have largely been associated with 
exposure to drinking water contaminated with these toxins (except BMAA), it is notable, 
although perhaps not surprising, that all of these recognized toxins are generally polar 
and water-soluble metabolites. Previous evaluation of crude, non-polar (i.e., chloroform) 
extracts from strains of both C. raciborskii and A. ovalisporum identified developmental 
toxicity, clearly unrelated to the presence of CYN, and specifically associated with 
apparent lipophilic metabolites from extracts of all of the isolates evaluated (Berry et al., 
2009). 
C. raciborskii has been specifically associated with the production of the 
hepatotoxic alkaloid, cylindrospermopsin (CYN), as well as the neurotoxic saxitoxin 
(STX) and its analogues. Aphanizomenon, as a genus, and particularly the species, A. 
flos-aquae, is a recognized producer of CYN, as well as the neurotoxic saxitoxin and 
anatoxin-a. Although A. ovalisporum is not known to produce either saxitoxin or 
anatoxin-a, studies of the Lake Kinneret isolate (Banker et al., 1997; Banker et al., 2000) 
identified both CYN and its 7-epimer (i.e., 7-epi-CYN). Interestingly, and relevant to the 
present study, during the isolation of the latter CYN congener, a series of isotactic 
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polymethoxy-1-alkenes (4-6; Figure 2.1) were concurrently identified, purified and 
chemically characterized. 
Indeed, in the present study, bioassay-guided fractionation, as described below, 
led to the isolation, and chemical characterization of these previously identified 
polymethoxy-1-alkenes (PMAs), i.e., 4-6, as well as three additional members (1-3) of 
the apparent homologous series (Figure 2.1), as lipophilic developmental toxins from the 
Lake Kinneret strain of A. ovalisporum. Although three of the six PMAs reported here 
have been isolated previously from this strain (Banker et al., 2000) - as well as at least 
two other genera (i.e., Scytonema, Tolypothrix) of the cyanobacterial order Nostocales 
(Mynderse and Moore, 1979; Mori et al., 1991a and 1991b) - in studies spanning more 
than three decades, they have not previously been associated with toxicity. In addition to 
their isolation, and chemical characterization, we report here on their developmental 
toxicity in the zebrafish embryo model, and specifically, the apparent synergistic activity 
of congeners in the series. 
 
 
Figure 2. 1: Structure of polymethoxy alkenes (1-6) isolated in the current and previous studies. 
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2.2. Results and Discussion 
2.2.1. Purification of PMAs by Bioassay-Guided Fractionation 
Biomass from unialgal cultures of A. ovalisporum was twice extracted in CHCl3, 
and pooled extracts were confirmed to inhibit zebrafish embryo development as 
previously documented (Berry et al., 2009). The pooled crude extracts were subsequently 
fractionated (see Experimental Section) by silica gel column chromatography and 
reverse-phase HPLC, affording a bioactive fraction containing a total of six components 
(1-6; Figure 2.2). LC-MS of the active fraction identified nominal masses of the 
presumptive molecular ions (M + H+) for compounds 1–6 of m/z 505 (1), 563 (2), 621 
(3), 679 (4), 737 (5) and 795 (6), in addition to apparent, i.e., M + 23, sodium adducts (M 
+ Na+)  and M + 39, potassium adducts (M + K+) of each (Figure 2.3). An incremental 
mass difference of 58 amu, corresponding to -CH2CH(OCH3)- units, between each of the 
six compounds, as well as collision induced fragmentations, corresponding to sequential 
losses of 32 amu (-OCH3 lost as CH3OH) for each compound, was consistent with a 
homologous series of PMAs, as previously observed for the strain (Banker et al., 2000) 
as well as other cyanobacteria (Mynderse and Moore, 1979; Mori et al., 1991a and 
1991b). Each of the six peaks was collected for subsequent chemical and toxicological 
characterization (as described below). 
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Figure 2. 2: Chromatogram showing PMAs (1-6) isolated by HPLC from A. ovalisporum. See 
experimental section for details. 
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Figure 2. 3: Low resolution LC-MS of the PMA mixture from A. ovalisporum showing all 6 PMAs isolated from the HPLC with the * 
indicating the [M+H]+ peaks, ♦ indicating the [M+Na]+ peaks, and • indicating the [M+K]+ peaks.  
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2.2.2. Structure Elucidation of the PMAs from A. ovalisporum 
Compound 3 was the most abundant of the purified compounds and was isolated 
as a white amorphous solid. A molecular formula of C34H68O9 was suggested by high-
resolution MS (HRMS; m/z 621.4920 [M + H]+), and subsequently confirmed by 1H and 
13C-NMR studies (see below). MS/MS of the presumptive molecular ion (m/z 621.5) in 
the triple quadrupole instrument identified nine sequential losses of 32 amu consistent 
with nine methoxy groups (as CH3OH) from the molecule (Figure 2.4). 1H NMR (Table 
1), likewise, revealed eight signals at δ 3.1641 (s, 3H), 3.2105 (s, 3H), 3.218 (s, 3H), 
3.2432 (s, 3H), 3.2514 (s, 3H), 3.2708 (s, 3H), 3.2745 (s, 3H) and 3.2798 (s, 6H), 
consistent with nine methoxy groups, with two of the methoxy groups being equivalent 
(Figure 2.5b). 
 
 
 
Figure 2. 4: LC-MS (low-resolution) of purified PMA 3 showing the sequential loss of m/z 32 
corresponding to the loss of methoxy groups. 
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Figure 2. 5: 1H-NMR of PMA 3 from A. ovalisporum; a) the total 1H-NMR spectrum and b) the 
signals observed for the methoxy protons showing 8 singlets corresponding to 9 methoxy groups 
(27H) with two of the methoxy groups being equivalent. 
 
Proton signals were observed at δH 5.09 (H-1E), 5.13 (H-1Z) and 5.93 (H-2), 
integrating to 3H, suggesting the presence of a terminal alkene, and a signal at δH 2.30, 
integrating to 2H, which suggests the presence of a methylene group attached to the 
terminal alkene determined based on the COSY correlation (see below). A triplet was 
 41 
 
observed at δH 0.91, integrating to 3H which was assigned to the methyl group (C-25). 
Two sets of overlapping multiplets at δ 3.37 (m, 2H) and 3.65 (m, 7H) (Table 2.1) were 
assigned as oxymethine hydrogens geminal to the methoxy groups as well as overlapping 
multiplets at δ 2.04 (m, 8H), 1.80 (m, 6H), 1.67 (m, 2H), 1.56 (m, 2H), 1.43 (m, 2H) and 
1.30 (m, 4H), which integrated to a total of 24 protons. Based on distinct chemical shifts, 
and the assumption that 3 was a PMA, 16 of these were tentatively assigned to the 
protons vicinal to methoxy groups (δ 2.04, 1.80 and 1.67), and the remaining eight 
protons (δ 1.56, 1.43 and 1.30) were assigned to methylenes at C-21 to C-24 positions 
(Figure 2.6). Tentative proton assignments, and the proposed molecular formula, were 
confirmed by 13C-NMR and DEPT, as well as subsequent COSY, HMQC and HMBC 
experiments, as described below. 
 
 
Figure 2. 6: Proposed structure of PMA 3 with carbons numbered. 
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Table 2. 1: 1H (C6D6, 400.13 MHz) and 13C (C6D6, 100.61 MHz) NMR Data for 
4,6,8,10,12,14,16,18,20-nonamethoxy-1-pentacosene from A. ovalisporum (3). 
C # δC  δH (mult, J in Hz; #H) COSY HMBC 
1 117.01 5.13 (dd,17,2; 1H)* 
5.09 (dd,10,2; 1H)* 
H-2 
H-2 
H2-3 
H2-3 
2 135.26 5.93 (ddt,17,10,7; 1H) H-1, H2-3 H2-3 
3 38.66 2.30 (m; 2H) H-2, H-4 H2-1, H1-2 
4 77.61 3.37 (m; 1H) H-3, H2-5 H3-26 
5, 7 ,9…19 38.35-38.97 1.67-2.04 (m; 16H) See text See text 
6, 8, 10…18 75.92-76.11 3.65 (m; 7H) See text See text 
20 78.13 3.37 (m; 1H) H2-21, H2-19 H3-34 
21 33.96 1.56 (m; 2H) H2-20, H2-22 See text 
22 25.09 1.43 (m; 2H) H2-21, H2-23 See text 
23 32.51 1.30 (m; 2H) H2-22, H2-24 See text 
24 23.08 1.30 (m; 2H) H2-23, H2-25 See text 
25 14.27 0.91 (t, 7.1; 3H) H2-24 H2-24, H2-23 
26-34 56.93-56.16 3.16-3.28 (s; 27H)  H-4,6…H-20 
*Due to poor resolution, further splitting could not have been determined beyond the doublet of 
doublet. 
 
 
Figure 2. 7: 1H-NMR of PMA 3 showing the terminal alkene 
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Figure 2. 8: 1H-NMR of PMA 3 showing the terminal methyl group. 
 
The DEPT-135 experiment helped to support the assignments of the protons from 
the 1H-NMR by indicating differentiating the presence of ‘CH’ and ‘CH3’ carbons 
(positive signals) from ‘CH2’ carbons (negative signals) (Figure 2.9). The experiment 
showed a positive carbon signal at δ 135.26 and a negative signal at δ 117.01 supporting 
the assignment of the terminal alkene, as well as a negative signal at δ 38.66 supporting 
the assignment of the allylic protons. A positive signal was observed at δ 14.27 which 
also supports the presence of a methyl group. Overlapping positive signals were observed 
between δ 56.93-56.16 and overlapping positive signals at δ 75.92-78.13 corresponding 
to the methoxy carbons (-OCH3) and the oxymethine carbons (-CHOCH3) respectively. 
Negative signals were also observed at δ 23.08, 25.09, 32.51, and 33.96 indicating 
methylene carbons which were assigned a chain of four CH2 connected to the terminal 
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methyl carbon (-CH2CH2CH2CH2CH3). The 1D 13C-NMR did not show additional carbon 
signals, suggesting that no quaternary carbons were present in the structure (Appendix 
A2.1.3D). 
 
Figure 2. 9: DEPT-135 experiment differentiating the ‘CH’ and ‘CH3’ carbons (positive signals) 
from the ‘CH2’ carbons (negative signals). 
 
 
COSY experiments, in conjunction with HMQC and HMBC, revealed the 
apparent linear structure of 3. Protons of the single methyl group (H3-25, δ 0.91) were 
found to correlate by COSY to two pairs of hydrogens (δ 1.30) that were revealed, by 
HMQC correlations, to be bonded to two methylene carbons (as confirmed by DEPT-
135). HMBC correlation of both methylene carbons to protons of the methyl group 
further enabled assignment of C-25, -24 and -23. COSY correlation of C-23/24 protons to 
a single pair of methylene protons (assigned as C-22), and subsequent correlation to a 
single adjacent pair of methylene protons (assigned as C-21) - as well as COSY 
correlation of C-21 hydrogens to a pair of oxymethine protons (δ 3.37) - enabled 
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assignments of hydrogens on C-25 through C-20. Similarly, at the alkene terminal, 
COSY correlation was observed between alkene hydrogens and a single pair of 
methylene protons that was consequently assigned to C-3. Although methylene protons 
on both C-21 and C-3 correlated to the same two overlapping oxymethine proton signals 
(assigned C-20 and C-4, respectively), correlation of these protons to C-22 methylene and 
C-1/2 terminal alkene protons, respectively, allowed these two pairs of methylene 
hydrogens to be clearly distinguished. 
The data from the heteronuclear 2D experiments (HMQC and HMBC) obtained 
for compound 3, were used to confirm the assignments of the chemical shifts and the 
connectivities within the structure. The HMBC data showed the correlation between the 
signal at δ 0.91 (CH3 protons) and the signals at δ 23.08 and 32.51 confirming the 
assignments of C-24 and C-23 respectively as previously established from the HMQC. 
The methylene signals at δ 1.30-1.56 did not show any correlation, possibly due to the 
low concentration of the sample. Correlations were also observed for the signal at δ 2.30 
(allylic CH2) with the signals at δ 77.61, 117.01, and 135.26 confirming the methylene 
connectivity to the terminal alkene as well as assigning the signal at δ 77.61 as C-4. 
Overlapping signals at δ 3.16-3.28 (methoxy protons) were coupled to the signals at δ 
75.92-76.11 (oxymethine carbons) and δ 38.35-38.97 (methylene carbons) which shows 
the 2 and 3 bond coupling between the heteroatoms confirming the assignments of the 
alternating methoxy groups. The other set of overlapping signals of the methylene 
protons at δ 1.67-2.04 were coupled to the signals at δ 75.92-76.11 (oxymethine carbons) 
and δ 38.35-38.97. 
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Figure 2. 10: Total COSY spectrum of PMA 3 from A. ovalisporum. 
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Figure 2. 11: COSY spectrum of PMA 3 from A. ovalisporum showing the methylene 
correlations. 
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Figure 2. 12: HMQC of PMA 3 from A. ovalisporum with terminal alkene zoomed in. 
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Finally, a stretch of nine alternating methoxy-bearing carbons and the methylene 
carbons between (C-4 to C-20; Figure 2.6) were identified based on correlations in COSY 
and HMBC. HMBC correlations between proposed methoxy carbons (nine in total) and 
seven remaining oxymethine protons, along with mass fragmentation (i.e., loss of 32 
amu) consistent with –OCH3 functional groups, further confirmed their identity as 
methoxy-bearing carbons. Chemical shifts, in both 1H- and 13C-NMR spectra, assigned to 
protons and carbons of the remaining methylenes and oxymethines, overlapped 
considerably, and did not consequently allow resolution of these signals for direct 
correlations. However, COSY and HMBC correlation of the total integrated signals for 
the methylene and oxymethine protons (i.e., 16 and 9, respectively) and corresponding 
carbons (i.e., 8 and 9, respectively) confirmed that methoxy-bearing carbons alternated 
with methylenes. 
Accordingly, 3 was determined to be 4,6,8,10,12,14,16,18,20-nonamethoxy-1-
pentacosene. As such, this compound would represent a structural isomer of 
4,6,8,10,12,14,16,18,22-nonamethoxy-1-pentacosene previously isolated from the same 
strain by Banker et al. (2000). Although a new PMA variant for this particular strain, 3 
was, in fact, previously isolated by Mynderse and Moore (1979) from Tolypothrix 
conglutinata var. colorata - specifically as the similarly most abundant (~80%) of three 
congeners isolated from this strain - as well as by Mori et al. (1991a) from Scytonema 
burmanicum. In this case, as in other prior studies (Banker et al., 2000; Mori et al., 1991a 
and 1991b), the methoxy groups of the PMA were determined, based on NMR studies, to 
be isotactic (i.e., on the same side of the alkene chain). Based on the nearly identical 1H- 
and 13C-NMR observed here, 3 was proposed to be, likewise, isotactic. 
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Although quantities of each of the less abundant PMAs purified, including the 
more major (i.e., 2 and 4) and minor (i.e., 1, 5 and 6; see Figure 2.2) congeners, did not 
generally allow for 13C-NMR and related NMR analysis (i.e., HMQC, HMBC), structures 
were assigned based on comparison to the 1H-NMR and associated assignments based on 
COSY of 3 (as described above), as well as MS/MS (i.e., losses of 32 amu corresponding 
each methoxy group). Furthermore, comparison of this data (i.e., 1H-NMR, COSY, MS) 
to that previously published and available for characterization of PMAs, and specifically, 
studies by Mynderse and Moore (1979) and Mori et al. (1991a and 1991b), were used to 
support these structural assignments. A clear correlation (e.g., nearly identical 1H-NMR 
chemical shifts, identical molecular ions and subsequent fragmentation patterns) between 
spectroscopic data obtained for 2 and 4-6 in the present study, as well as those previously 
reported (Mynderse and Moore, 1979; Banker et al., 2000; Mori et al., 1991a), support 
our structural determinations for these less abundant variants. On the other hand, 
although 1 has not been previously identified from any other source, consistency in the 
NMR and MS data for this congener, compared to the other purified in the present study, 
strongly support the proposed structure of this variant. Similar to 3, the stereochemistry - 
and specifically the assignment as isotactic methoxy groups - was, likewise, concluded 
based on the similarities observed in the NMR data for these congeners and those 
previously characterized (Banker et al., 2000; Mori et al., 1991a and 1991b). 
Accordingly, 1 and 2 were identified as isotactic 4,6,8,10,12,14,16-heptamethoxy-1-
uncosene and 4,6,8,10,12,14,16,18-octamethoxy-1-tricosene, respectively. The former 
variant (1) has not been previously isolated (to the authors’ knowledge) from 
cyanobacteria, however, the latter (2) was previously isolated from T. conglutinata 
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(Mynderse and Moore, 1979). On the other hand, 4-6 were identified as 
4,6,8,10,12,14,16,18,20,22-decamethoxy-1-heptacosene, 4,6,8,10,12,14,16,18,20,22,24-
undecamethoxy-1-nonacosene and 4,6,8,10,12,14,16,18,20,22,24,26-dodecamethoxy-1-
hentriacontene, respectively, and each has been previously isolated from the Lake 
Kinneret isolate of A. ovalisporum (Banker et al., 2000) and other cyanobacteria (Mori et 
al., 1991a and 1991b). Additional members of the apparent homologous series, including 
penta- and hexa-methoxylated variants, although not seen here, have been previously 
isolated from species of Scytonema (Mori et al., 1991a and 1991b). 
 
2.2.3. Structure Elucidation of the PMAs from C. raciborskii 
Purification of the PMAs from C. raciborskii was done according to the procedure 
as describe for A. ovalisporum. Five of the six PMAs isolated from A. ovalisporum were 
identified in C. raciborskii, based on the high-resolution LC-MS data (Figure 2.14), 
however only four of the PMAs (2-5) were purified by HPLC (Figure 2.13). The resulting 
chemical characterization was similar to the PMAs isolated from A. ovalisporum and the 
other cyanobacterial stains previously shown to produce these compounds (Mynderse and 
Moore, 1979; Mori et al., 1991a and 1991b; Rao and Faulkner, 2002; Jaja-Chimedza et 
al., 2012). All four compounds obtained from the purification were white amorphous 
solids.  High-resolution mass spectral data for all four compounds were obtained; 
[M+H]+ 563.4488 (2), 621.4900 (3), 679.5312 (4), and 737.5733 (5), which allowed for 
the determination of the molecular formulas C31H62O8 (2), C34H68O9 (3), C37H74O10 (4), 
C40H80O11 (5), which were further confirmed by NMR analyses.  
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Figure 2. 13: HPLC Chromatogram of the four PMAs purified from C. raciborskii with UV 
detection at 200 nm. 
 
 
Figure 2. 14: High resolution LC-MS analysis of a crude fraction of C. raciborskii showing the 
presence of five PMAs (1-5); a) chromatogram of the PMAs and b) mass spectral data of the 
PMAs. 
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Fragmentation of the molecular ion of each of the compounds showed a sequential 
loss of m/z 32 corresponding to the number of methoxy groups associated with the 
compound, indicating the presence of a polymethoxylated structure. Mass spectral data 
also showed that the masses of the four polymethoxy-1-alkenes differed from the next by 
a mass of 58, corresponding to the -CH2CH(OCH3)- unit (See Figure 2.14). This is 
consistent with that observed from the polymethoxy-1-alkenes isolated from other 
cyanobacterial strains (Mynderse and Moore, 1979; Mori et al., 1991a and 1991b; Banker 
et al., 2000; Jaja-Chimedza et al., 2012) and sponge (Rao and Faulkner, 2002). 
 
 
Figure 2. 15: 1H-NMR of PMA 3 from C. raciborskii; a) the total 1H-NMR spectrum and b) the 
signals observed for the methoxy protons showing 8 singlets corresponding to 9 methoxy groups 
(27H) with two of the methoxy groups being equivalent. 
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The NMR data showed signals and splitting patterns were similar to those observed 
for the PMAs isolated from the other strains of cyanobacteria. 1H and COSY NMR 
spectroscopic data were obtained for all the compounds with the exception of PMA 2 due 
to the low amount of the compound purified (57μg). Chemical shifts and connectivities 
were similar for all three compounds and so analysis of compound 3 will represent what 
was observed for the other two PMAs. The 1H-NMR showed 8 signals at δ 3.1637 (s, 
3H), 3.2101 (s, 3H), 3.2174 (s, 3H), 3.2427 (s, 3H), 3.2508 (s, 3H), 3.2705 (s, 3H), 
3.2742 (s, 3H), and 3.2792 (s, 6H) corresponding to 9 methoxy groups. The NMR signals 
for the terminal alkenes were observed at δ 5.07 (1H-1E), 5.10 (1H-1Z), and 5.90 (ddt, 
1H-2), which was coupled to the signal at δ 2.30 (2H-3) for the methylene hydrogens (m; 
2H). The methylene signal was then coupled to a signal δ 3.37 corresponding to one of 
the oxymethine hydrogens (2H), designated H-4. The signals observed at δ 0.91 (t; 3H), 
1.30 (m; 4H), 1.42 (m; 2H), and 1.56 (m; 2H), corresponds to the terminal methyl group 
and subsequent methylene groups respectively, making up the alkyl chain (-
CH2CH2CH2CH2CH3) at the end of the molecule, based on the couplings observed from 
the COSY experiment. The methylene signal at δ 1.56 (m; 2H) was then coupled to an 
oxymethine signal at δ 3.37, designated H-20. The oxymethine multiplets at δ 3.37 and 
3.64 (8H) were coupled to the overlapping multiplets from δ 1.67 – 2.03 (16H). 
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Table 2. 2: 1H (C6D6, 400.13MHz) and 13C (C6D6, 100.61MHz) NMR data for 
4,6,8,10,12,14,16,18,20-nonamethoxy-1-pentacosene (3) from C. raciborskii. 
C # δC  δH (mult, J in Hz; 
#H) 
COSY HMBC 
1 117.35 5.10 (dd, 17,2; 1H) 
5.07 (dd, 10,2; 1H) 
H-2 
H-2 
H2-3  
H2-3  
2 135.56 5.90 (ddt,17,10,7; 1H) H-1, H2-3 H2-3 
3 38.35 2.30 (m; 2H) H-2, H-4 H2-1, H1-2 
4 77.89 3.37 (m; 1H) H-3, H2-5 H3-26  
5, 7 ,9…19 38.54-38.97 1.67-2.03 (m; 16H) See text See text 
6, 8, 10…18 75.92-76.11 3.64 (m; 7H) See text See text 
20 78.42 3.37 (m; 1H) H2-21, H2-19 H3-34  
21 34.26 1.56 (m; 2H) H2-20, H2-22 See text 
22 25.40 1.42 (m; 2H) H2-21, H2-23 See text 
23 32.82 1.30 (m; 2H) H2-22, H2-24 See text 
24 23.40 1.30 (m; 2H) H2-23, H2-25 See text 
25 14.60 0.91 (t, 7.1; 3H) H2-24 H2-24, H2-23  
26-34 56.24-56.47 3.16-3.28 (s; 27H)  H-4,6…H-20 
 
The heteronuclear 2D experiments, HMQC and HMBC data were obtained for 
compound 3 which were used to confirm the assignments of the chemical shifts and 
determine the long range connectivities between the protons and carbons respectively 
(See Table 1). The HMBC data showed the connectivities of the methoxy proton signals 
at δ 3.16-3.28 coupled to signals at δ 75.92-78.42, the oxymethine signals at δ 3.37-3.64 
coupled to the signals at δ 56.24-56.47 and the methylene protons at δ 1.67-2.03 coupled 
to signals at δ 75.92-78.42. Specific correlations were observed for the methylene protons 
at δ 2.30 coupled to the terminal alkene signals (δ 5.07, 5.10, and 5.90) and the signal at δ 
77.89 (designated C-4). The terminal methyl signal at δ 0.91 was coupled to the signals at 
δ 23.40 and 32.82 confirming the designations of C-24 and C-23 respectively. The NMR 
and mass spectral data obtained correlates with those observed for other PMAs identified 
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in other strains of cyanobacteria (Mynderse and Moore, 1979; Mori et al., 1991; Jaja-
Chimedza et al., 2012). 
The PMAs isolated in this study, with the exception of PMA 1, were previously 
isolated from other strains of cyanobacteria, however not enough material was purified to 
obtain relative or absolute stereochemistry. However, the absolute stereochemistry of the 
PMAs isolated from the cyanobacteria, Scytonema, were determined by carrying out a 
direct comparison with the optically active synthetic compounds (Mori et al., 1991a and 
1991b). Based on the synthesis, it was determined that the PMA from S. burmanicum and 
S. ocellatum (Mori et al., 1991a), specifically the nonamethoxy-1-pentacosene, was 
slightly different in structure from the PMA from S. ocellatum (Mori et al., 1991b) with 
the location of one of the methoxy groups (C-34) being on C-22 instead of C-20 (Figure 
2.16). Other PMAs with a similar structure were also isolated from S. ocellatum with one 
of the methoxy groups being located on a different carbon atom. These two structures 
however differed slightly in their chemical shifts as well as their optical rotation (done in 
CHCl3 at 25oC, c = +4.73 for 4,6,8,10,12,14,16,18,20-nonamethoxy-1-pentacosene and c 
= +11.20 for 4,6,8,10,12,14,16,18,22-nonamethoxy-1-pentacosene). The NMR data 
obtained for PMA 3 in this study supports the assignment of 4,6,8,10,12,14,16,18,20-
nonamethoxy-1-pentacosene, however not enough sample was obtained to do optical 
rotation for further confirmation based on the synthesis of these compounds in the 
previous studies. 
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Figure 2. 16: Two different forms of nonamethoxy-1-pentacosene isolated from different species 
of Scytonema previously determined by synthesis (Mori et al., 1991a and 1991b) 
 
A model of the 3D structure of PMA 3 (based on the proposed structure as 
determine above) was generated using Chem3D Pro 12.0 Ink which shows the structure 
resembling a cork screw with the methoxy groups sticking out of the carbon backbone 
(Figure 2.17). 
 
Figure 2. 17: A model of the 3D structure of PMA 3 from Chem3D Pro 12.0 Ink. 
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2.3. Experimental Section 
2.3.1. Culturing of the Cyanobacteria 
The isolates of A. ovalisporum, (designated APH 127-1) and C. raciborskii 
(designated CAQS) were grown, as previously described (Berry et al., 2007; Berry et al., 
2009; Gantar et al., 2008), in 3-L flasks in BG11 medium under cool-white fluorescent 
light (intensity 30 μEm-2·s-1) with aeration. The cells/biomass were harvested after three 
to four weeks by centrifugation and freeze-dried. 
 
2.3.2. Extraction and Isolation of Polymethoxy-1-alkenes 
Isolation and purification of the polymethoxy-1-alkenes was carried out by a 
bioassay-guided fractionation using the zebrafish embryo model. Freeze-dried biomass of 
A. ovalisporum and C. raciborskii was extracted in chloroform in a 10:1 ratio overnight. 
The filtered extract was initially fractionated by flash chromatography on a normal phase 
silica-gel glass column (Silica Gel 60Å, Commercial 40–63 μm) with a stepwise gradient 
of ethyl acetate in hexane; a bioactive fraction (as identified with the zebrafish embryo 
toxicity assay; see Chapter 4) eluted with 100% ethyl acetate. This bioactive (i.e., 100% 
ethyl acetate) fraction was further separated by reverse-phase HPLC (Phenomenex Luna 
5 μm C18 100 Å LC Column 250 × 4.6 mm; solvent gradient of 50:50 acetonitrile/water 
to 100% acetonitrile for 37 min at a flow rate of 1ml/min) with UV detection (i.e., 200 
nm absorbance). The crude mixture of all six polymethoxy-1-alkenes eluted with 
retention times between 21 and 24 min. This mixture of polymethoxy-1-alkenes was 
confirmed to be toxic in the zebrafish embryo model (see Chapter 4), and individual 
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PMAs were purified by HPLC-UV (isocratic 65:35 acetonitrile/water) with the 
compounds eluting in order of increasing size (see Figure 2.2 and 2.3). 
 
2.3.3. Characterization of Polymethoxy-1-alkenes from A. ovalisporum 
Purified compounds were characterized by NMR and mass spectrometry. 1H- and 
13C/DEPT-135 NMR, as well as two-dimensional homonuclear (i.e., COSY) and 
heteronuclear (i.e., HMQC and HMBC) analyses, were done on a Bruker AVANCE 400 
MHz instrument. Mass spectrometry was performed on a Thermo TSQ Quantum Access 
ESI/triple quadrupole instrument coupled to a Thermo Accela UHPLC; high-resolution 
mass spectrometry data was done on a Thermo LTQ ESI-Orbitrap.  
 
4,6,8,10,12,14,16-Heptamethoxy-1-uncosene (1): HRESIMS m/z 505.4067 (C28H56O7, 
[M + H]+, mmu of -3.18); 1H NMR (400 MHz, benzene-d6) δ 0.91 (t, 3H, J = 7.1 Hz), 
1.30 (m, 4H), 1.43 (m, 2H), 1.56 (m, 2H), 1.67 (m, 2H), 1.81 (m, 4H), 2.02 (m, 6H), 2.30 
(m, 2H), 3.16 (s, 3H), 3.21 (s, 3H), 3.22 (s, 3H), 3.24 (s, 3H), 3.25 (s, 3H), 3.27 (s, 3H), 
3.27 (s, 3H), 3.37 (m, 2H), 3.64 (m, 5H), 5.07 (dd, 1H, J = 10,2 Hz), 5.09 (dd, 1H, J = 17, 
2 Hz), 5.90 (ddt, 1H, J = 17, 10, 7 Hz). 
 
4,6,8,10,12,14,16,18-Octamethoxy-1-tricosene (2): HRESIMS m/z 563.4222 (C31H62O8, 
[M + H]+, mmu of -3.56); 1H NMR (400 MHz, benzene-d6) δ 0.91 (t, 3H, J = 7.1 Hz), 
1.30 (m, 4H), 1.42 (m, 2H), 1.56 (m, 2H), 1.67 (m, 2H), 1.81 (m, 5H), 2.03 (m, 7H), 2.30 
(m, 2H), 3.16 (s, 3H), 3.21 (s, 3H), 3.22 (s, 3H), 3.24 (s, 3H), 3.25 (s, 3H), 3.27 (s, 3H), 
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3.27 (s, 3H), 3.28 (s, 3H), 3.37 (m, 2H), 3.64 (m, 6H), 5.07 (dd, 1H, J = 10, 2 Hz), 5.09 
(dd, 1H, J = 17, 2 Hz), 5.90 (ddt, 1H, J = 17, 10, 7 Hz). 
 
4,6,8,10,12,14,16,18,20-Nonamethoxy-1-pentacosene (3): HRESIMS m/z 621.4900 
(C34H68O9, [M + H]+, mmu of -3.95); 1H NMR (400 MHz, benzene-d6) δ 0.91 (t, 3H, J 
= 7.1 Hz), 1.30 (m, 4H), 1.43 (m, 2H), 1.56 (m, 2H), 1.67 (m, 2H), 1.80 (m, 6H), 2.04 
(m, 8H), 2.30 (m, 2H), 3.1641 (s, 3H), 3.2105 (s, 3H), 3.218 (s, 3H), 3.2432 (s, 3H), 
3.2514 (s, 3H), 3.2708 (s, 3H), 3.2745 (s, 3H), and 3.2798 (s, 6H), 3.37 (m, 2H), 3.65 (m, 
7H), 5.09 (dd, 1H, J = 10, 2 Hz), 5.13 (dd, 1H, J = 17, 2 Hz), 5.93 (ddt, 1H, J = 17, 10, 7 
Hz); 13C NMR (100 MHz, benzene-d6) δ 14.3, 23.1, 25.1, 32.5, 33.9, 38.0, 38.2, 38.3, 
38.6, 38.6 (3C), 38.7 (4C), 55.9, 56.0, 56.0 (3C), 56.0 (2C), 56.1, 56.1, 75.6, 75.7 (2C), 
75.7, 75.8, 77.6, 78.1, 117.0, 135.3. 
 
4,6,8,10,12,14,16,18,20,22-Decamethoxy-1-heptacosene (4): HRESIMS m/z 679.5312 
(C37H74O10, [M + H]+, mmu of -4.08); 1H NMR (400 MHz, benzene-d6) δ 0.91 (t, 3H, J 
= 7.1 Hz), 1.30 (m, 4H), 1.44 (m, 2H), 1.58 (m, 2H), 1.68 (m, 2H), 1.81 (m, 7H), 2.03 
(m, 9H), 2.30 (m, 2H), 3.16 (s, 3H), 3.21 (s, 3H), 3.22 (s, 3H), 3.24 (s, 3H), 3.25 (s, 3H), 
3.27 (s, 3H), 3.27 (s, 3H), 3.28 (s, 9H), 3.37 (m, 2H), 3.64 (m, 8H), 5.07 (dd, 1H, J = 10, 
2 Hz), 5.10 (dd, 1H, J = 17, 2 Hz), 5.90 (ddt, 1H, J = 17, 10, 7 Hz). 
 
4,6,8,10,12,14,16,18,20,22,24-Undecamethoxy-1-nonacosene (5): HRESIMS m/z 
737.5728 (C40H80O11, [M + H]+, mmu of -4.51); 1H NMR (400 MHz, benzene-d6) δ 
0.91 (t, 3H, J = 7.1 Hz), 1.30 (m, 4H), 1.44 (m, 2H), 1.57 (m, 2H), 1.68 (m, 2H), 1.81 (m, 
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8H), 2.03 (m, 10H), 2.30 (m, 2H), 3.16 (s, 3H), 3.21 (s, 3H), 3.22 (s, 3H), 3.24 (s, 3H), 
3.25 (s, 3H), 3.27 (s, 6H), 3.27 (s, 3H), 3.28 (s, 9H), 3.37 (m, 2H), 3.64 (m, 9H), 5.07 
(dd, 1H, J = 10, 2 Hz), 5.10 (dd, 1H, J = 17, 2 Hz), 5.90 (ddt, 1H, J = 17, 10, 7 Hz). 
 
4,6,8,10,12,14,16,18,20,22,24,26-Dodecamethoxy-1-hentriacontene (6): HRESIMS m/z 
795.6150 (C43H86O12, [M + H]+, mmu of -4.22); 1H NMR (400 MHz, benzene-d6) δ 
0.91 (t, 3H, J = 7.1 Hz), 1.30 (m, 4H), 1.44 (m, 2H), 1.57 (m, 2H), 1.68 (m, 2H), 1.81 (m, 
9H), 2.03 (m, 11H), 2.30 (m, 2H), 3.16 (s, 3H), 3.21 (s, 3H), 3.22 (s, 3H), 3.24 (s, 3H), 
3.25 (s, 3H), 3.27 (s, 6H), 3.27 (s, 3H), 3.28 (s, 12H), 3.37 (m, 2H), 3.64 (m, 10H), 5.07 
(dd, 1H, J = 10, 2 Hz), 5.10 (dd, 1H, J = 17, 2 Hz), 5.90 (ddt, 1H, J = 17, 10, 7 Hz). 
 
2.3.4. Characterization of Polymethoxy-1-alkenes from C. raciborskii 
Purified compounds were characterized by NMR and mass spectrometry. 1H- and 
13C/DEPT-135 NMR, as well as two-dimensional homonuclear (i.e., COSY) and 
heteronuclear (i.e., HMQC and HMBC) analyses, were done on a Bruker AVANCE 400 
MHz instrument. Mass spectrometry was performed on a Thermo TSQ Quantum Access 
ESI/triple quadrupole instrument coupled to a Thermo Accela UHPLC; high-resolution 
mass spectrometry data was done on a Thermo LTQ ESI-Orbitrap. 
 
4,6,8,10,12,14,16,18-Octamethoxy-1-tricosene (2): HRESIMS m/z 563.4489 (C31H62O8, 
[M + H]+, mmu of -2.90); 1H NMR (400 MHz, benzene-d6) 3.1643 (s, 3H), 3.2114 (s, 
3H), 3.2185 (s, 3H), 3.2437 (s, 3H), 3.2525 (s, 3H), 3.2715 (s, 3H), 3.2750 (s, 3H), 
3.2810 (s, 3H). 
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4,6,8,10,12,14,16,18,20-Nonamethoxy-1-pentacosene (3): HRESIMS m/z 621.4900 
(C34H68O9, [M+H]+, mmu of -3.64); 1H NMR (400MHz, benzene-d6) δ 0.91 (t, 3H, J = 
7.1 Hz), 1.30 (m, 4H), 1.42 (m, 2H), 1.56 (m, 2H), 1.67 (m, 2H), 1.81 (m, 6H), 2.03 (m, 
8H), 2.30 (m, 2H), 3.1637 (s, 3H), 3.2101 (s, 3H), 3.2174 (s, 3H), 3.2427 (s, 3H), 3.2508 
(s, 3H), 3.2705 (s, 3H), 3.2742 (s, 3H), and 3.2792 (s, 6H), 3.37 (m, 2H), 3.64 (m, 7H), 
5.07 (dd, 1H, J = 10,2 Hz), 5.10 (dd, 1H, J = 17,2 Hz), 5.90 (ddt, 1H, J = 17,10,7 Hz); 
13C NMR (100MHz, benzene-d6) δ 14.6, 23.4, 25.4, 32.8, 34.3, 38.3, 38.5, 38.6, 38.9, 
38.9 (3C), 39.0 (4C), 52.2, 56.3, 56.3 (3C), 56.4 (2C), 56.5, 75.9, 76.0 (2C), 76.1, 76.1, 
77.9, 78.4, 117.3, 135.6. 
 
4,6,8,10,12,14,16,18,20,22-Decamethoxy-1-heptacosene (4): HRESIMS m/z 679.5312 
(C37H74O10, [M+H]+, mmu of -4.27); 1H NMR (400MHz, benzene-d6) δ 0.91 (t, 3H, J = 
7.1 Hz), 1.30 (m, 4H), 1.42 (m, 2H), 1.55 (m, 2H), 1.67 (m, 2H), 1.81 (m, 7H), 2.02 (m, 
9H), 2.30 (m, 2H), 3.16 (s, 3H), 3.21 (s, 3H), 3.22 (s, 3H), 3.24 (s, 3H), 3.25 (s, 3H), 3.27 
(s, 3H), 3.27 (s, 3H), 3.28 (s, 9H), 3.37 (m, 2H), 3.65 (m, 8H), 5.07 (dd, 1H, J = 10,2 Hz), 
5.10 (dd, 1H, J = 17,2 Hz), 5.90 (ddt, 1H, J = 17,10,7 Hz). 
 
4,6,8,10,12,14,16,18,20,22,24-Undecamethoxy-1-nonacosene (5): HRESIMS m/z 
737.5733 (C40H80O11, [M+H]+, mmu of -4.08); 1H NMR (400MHz, benzene-d6) δ 0.91 
(t, 3H, J = 7.1 Hz), 1.30 (m, 4H), 1.44 (m, 2H), 1.58 (m, 2H), 1.68 (m, 2H), 1.81 (m, 8H), 
2.04 (m, 10H), 2.30 (m, 2H), 3.16 (s, 3H), 3.21 (s, 3H), 3.22 (s, 3H), 3.24 (s, 3H), 3.25 (s, 
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3H), 3.27 (s, 6H), 3.28 (s, 12H), 3.37 (m, 2H), 3.65 (m, 9H), 5.07 (dd, 1H, J = 10,2 Hz), 
5.10 (dd, 1H, J = 17,2 Hz), 5.90 (ddt, 1H, J = 17,10,7 Hz). 
 
2.4. Conclusions 
In the present study, the zebrafish embryo model was used to identify, isolate (via 
bioassay-guided fractionation) and characterize a homologous series (Figures 2.1 and 2.2) 
of isotactic PMAs, including one novel variant, as toxic components of the lipophilic 
fraction of the Lake Kinneret isolate of A. ovalisporum and the Australia isolate of C. 
raciborskii. To our knowledge, this is the first report of the PMAs as toxic or otherwise 
bioactive metabolites. It is, accordingly, suggested that these metabolites may not only 
explain previously observed developmental toxicity (Berry et al., 2009) of lipophilic 
fractions from A. ovalisporum and C. raciborskii, but that these previously unrecognized 
(as toxic) components may contribute to the overall toxicity of these CYN-producing 
bloom species, and to the cyanobacteria perhaps more generally. Indeed, the prior 
isolation of these compounds (albeit as non-toxic metabolites) from other cyanobacterial 
species (Banker et al., 2000; Mynderse and Moore, 1979; Mori et al., 1991a and 1991b; 
Rao and Faulkner, 2002) may suggest that these toxic metabolites are relatively 
widespread, particularly within the cyanobacteria. As such, these findings suggest a need 
to further investigate these possibly widespread toxic metabolites of the cyanobacteria. 
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CHAPTER 3 
 
THE APPARENT BIOSYNTHETIC PATHWAY FOR POLYMETHOXY-1-ALKENES 
AND THEIR TAXONOMIC DISTRIBUTION IN DIFFERENT GENERA OF 
FRESHWATER CYANOBACTERIA  
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3.1. Introduction 
It has been suggested that these PMAs are derived from the polyketide biosynthetic 
pathway on the basis of their linear polymethoxylated structure, specifically their pattern 
of 1,3-oxygenation, and their isolation with other toxins biosynthesized by this pathway 
(i.e., cylindrospermopsin; Banker et al., 2000). It was also suggested that these 
compounds are produced by the bacteria (A. ovalisporum) only when it was producing 
CYN because PMAs could not be identified when the strain stopped producing the 
cyanotoxin (Banker et al., 2000). This could indicate that PMAs are synthesized by 
similar mechanisms to those of CYN as a result of the loss of production of these two 
metabolites at the same time. According, this hypothesis was further tested to identify if 
the biosynthesis of the PMAs involved the PKS biosynthetic pathway. Additionally, these 
PMAs have been isolated from over three decades ago on the basis of their structure and 
have subsequently been found in various other strains terrestrial, marine, and freshwater 
cyanobacteria belonging to the order Nostocales (Mynderse and Moore, 1979; Mori et 
al.,1991a and 1991b; Banker et al., 2000). It was therefore thought that these compounds 
may be widespread and so a culture collection of different genera of cyanobacteria was 
obtained to determine the prominence of these compounds. 
 
3.1.1. Polyketide synthases biosynthetic pathway 
The linear polymethoxylated structure of the PMAs suggests a possible 
biosynthetic origin based on the polyketide synthase (PKS) pathway found conspicuously 
throughout the secondary metabolism of fungi, bacteria and microalgae (Staunton and 
Weissman, 2001). Indeed, this biosynthetic route - and specifically the sequential 
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condensation of acetate - for the PMAs has been previously suggested by other authors. 
Banker et al. (2000), for example, proposed such a biosynthetic origin as a result of both 
consideration of structure, and the observation that PMAs were not found among A. 
ovalisporum cultures that lost their ability to produce the PKS-derived CYN. Similarly, 
both Mynderse and Moore (1979) and Mori et al. (1991a and 1991b) identified PMAs 
from strains of Tolypothrix and Scytonema, respectively, known to produce the 
polyketide, tolytoxin. Given the abundance of PKS-derived secondary metabolites among 
cyanobacteria (examples Figure 3.1) and other microalgae, this biosynthetic origin may 
further support a widespread distribution of the PMAs.  
 
 
Figure 3. 1: Structure of compounds from freshwater cyanobacteria with biosynthesis involving 
the PKS biosynthetic pathway. 
 
Polyketides are a diverse group of secondary metabolites that are commonly found 
in microorganisms (bacteria, fungi and microalgae) and are produced by a family of 
modular enzymes called polyketide synthases (PKSs). The carbon backbone of the 
polyketides is biosynthesized by way of Claisen Condensation of acyl coenzyme A 
(CoA), using acetate as the starter units, and further modified into bioactive metabolites 
(Snyder et al., 2003).  
Microcystin
Cylindrospermopsin 
Anatoxin-a
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Microorganisms that produce these readily uptake labeled substrates for the 
biosynthesis of metabolites (Staunton and Weissman, 2001) and as such feeding 
experiments with 13C-labeled acetate is commonly carried out to confirm biosynthesis via 
the PKS pathway. In the current study, we report the identification and purification of a 
series of PMAs (2-5) from a cultured strain of C. raciborskii (designated CAQS), 
originally isolated from an aquaculture pond in Australia (Saker and Eaglesham, 1999) 
and the suggested biosynthesis via the polyketide biosynthetic pathway. 
 
3.1.2. Previously identified genera of PMA-producing cyanobacteria 
Polymethoxy-1-alkenes (2-4) were first isolated from a terrestrial tolytoxin-
producing cyanobacterium, Tolypothrix because of its unusual structure (Mynderse & 
Moore, 1979). More than a decade later, these PMAs were isolated from another 
tolytoxin-producing cyanobacterium, Scytonema burmanicum, with two additional 
variants (n = 5 and n = 6) being found in S. mirabile (Mori et al., 1991a). Additionally 
variations to these PMAs were identified in S. ocellatum, a cultured terrestrial tolytoxin-
producing cyanobacterium (Mori et al., 1991b). Another decade later, similar PMAs (3-
6) were identified in a cultured cylindrospermopsin-producing strain of A. ovalisporum, 
isolated from Lake Kinneret, Israel. These PMAs were isolated according to their 
structure because there were no signs of bioactivity by the conventional cell-based 
assays. Recently, the zebrafish embryo was used in a bioassay-guided fraction for the 
isolation of six PMAs from A. ovalisporum, with a novel variant (1, n =7), showing that 
these compounds are indeed bioactive, thus contributing to the toxicity of these toxin-
producing cyanobacterial strains.  
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3.2. Results & Discussion 
3.2.1. Biosynthetic Origin of PMAs 
In order to investigate the possible biosynthetic origins of the 2-5, and specifically 
the possible involvement of PKS pathways, cultures of C. raciborskii AQS were fed 1-
13C-labeled acetate (as a recognized “building blocks” of PKS-derived polyketides).  
Subsequently, 2-5 were purified (as for unlabeled cultures; see Experimental Section 
2.3.2) from 13C-acetate-fed C. raciborskii cultures. Purified 2-5 were then analyzed for 
the incorporation of 13C by LC-MS and NMR spectroscopy (1D: Inverse-gated decoupled 
13C).   
 
Mass spectrometric analysis of the 13C-labeled PMAs: From partial purification of 
the PMAs from CAQS fed with 13C1-labeled acetate, we identified all six PMAs (1-6) 
that were previously identified in A. ovalisporum, including minor uncharacterized 
PMAs, with only 2-5 purified in sufficient quantities. All the PMAs identified showed 
incorporation of 13C as determined by the sequence of additional peaks with a m/z 1 
observed in the MS data, suggesting that these compounds are synthesized via the PKS 
pathway (Figure 3.2). PMA 3 was obtained in the highest quantity and was therefore used 
for further LC-MS and NMR analysis. Analysis by LC-MS of purified 3 (Figure 3.3) 
showed clear incorporation of 13C-heavy atom, and specifically a sequential ladder of 
masses starting from m/z 643 [M+Na]+ to m/z 658, indicating that a possible fourteen 13C-
atoms may have been incorporated (according to the number of additional m/z of +1 
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observed). All the other PMAs showed a sequential ladder of m/z of +1, again indicating 
the incorporation of the 13C atoms into the molecules (Figure 3.2). 
 
 
Figure 3. 2: LC-MS analysis of the isolated PMAs from CAQS showing the incorporation of the 
13C1-labeled acetate as shown from the additional m/z of +1. 
 
 
Figure 3. 3: LC-MS analysis of purified 3 from C-AQS after the feeding experiments with the 
labeled 13C1-acetate. 
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The incorporation of 13C-label via exogenous acetate generally confirms that 2-5 
were biosynthesized by the cultured organism.  It also indicates that this incorporation 
from acetate, as biosynthetic building blocks, or alternatively by metabolic/catabolic 
products derived from acetate.  The incorporation is also generally consistent with the 
PKS biosynthesis, however, to confirm that the pattern is by means of sequential 
condensation of the acetate building blocks (according to the PKS mechanisms), NMR 
studies were required. 
 
NMR Analysis of the 13C-Labeled PMAs: The specific areas of 13C incorporation 
were determined by NMR spectroscopy where an increase in the signals (relative to the 
unlabeled signals) of the corresponding chemical shifts indicated an incorporation of the 
carbon isotope. Isotopic enrichment was calculated using the method by Liu et al. (2012) 
by determining the integration of the carbon signals for both the natural abundance and 
enriched samples, and then calculating the percent of enrichment of the enriched sample 
compared to the natural abundance sample. Signals showing enrichment greater than 
200% indicates regions of incorporation. The purified samples of PMA 3 (both enriched 
and natural abundance) were analyzed by NMR using the inverse-gated decoupled 13C 
experiment in order to reduce the enhancement effects from the attached protons. Carbon 
signals were integrated for both samples, normalizing to a signal that is not expected to 
be enriched and calculated for percent enrichment. 
 Assignments of the chemical shifts and the corresponding percent enrichment for 
each signal is shown below in Table 3.1. Integration of the signals were normalized to C-
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25 and the overlapping signals were divided by the corresponding number of carbons for 
the final % enrichment. Incorporation of the 13C-isotope was expected in the oxymethine 
carbons (C-6, 8, 10,…,20) according to the patterns observed with the PKS pathway. 
Enrichment was observed in the carbons assigned 1, 2, 22, 23, 24, and 25 which was not 
in agreement with what was expected. As a result of the overlap of the signals for the 
oxymethine carbons (C-6,8,…,18), methylene carbons (C-3,5,…,19), and the methoxy 
carbons (C26-34), determination of individual enrichments was not possible.  
 
 
Table 3. 1: Assignments of the carbons from 13C-NMR and the percent enrichment of each signal. 
Integration of the signals was normalized to C-25. 
Carbon assignments δC (ppm) Percent enrichment (%) 
2 117.35 385.6 
1 135.56 407.6 
4 77.89 149.8 
20 78.42 125.2 
3,5,7,..,19 38.35-38.97 45.7 
26-34 56.24-56.47 22.4 
6,8,10,…,18 75.92-76.11 40.7 
21 34.26 186.6 
23 32.82 234.6 
22 25.40 276.7 
24 23.40 218.7 
25 14.60 228.4 
 
From the analysis of the NMR spectrum (Figure 3.4), splitting of the NMR signals 
was observed in all the individual carbon signals (C1, C2, C3, C4, C20, C21, C22, C23, 
C24, and C25) and partially in the overlapping signals of the oxymethine carbons (C6, 
C8,…, C18) observed at δ 75.9-76.1 as well as the overlapping methylene carbons (C5, 
C7,…,C19) observed at δ 38.9-39.0. As expected, there was no coupling observed for the 
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methoxy carbons due to the presence of the adjacent heteroatom. The couplings observed 
with the carbon signals indicate that there is incorporation of the 13C-isotope throughout 
the alkyl chain of the molecule and not just in alternating signals as hypothesized 
according to the PKS pathway. This ubiquitous incorporation of the 13C atom suggests 
that the 13C1-labeled acetate was possibly metabolized and utilized by a different 
biosynthetic pathway which uses the 13C atoms to synthesize the PMAs. Further analysis 
is required to identify how these labeled carbon atoms are being incorporated into the 
molecule. 
 
 
 
Figure 3. 4: Inverse-gated decoupled 13C-NMR spectrum of purified 3. 
 
The biosynthesis of PMAs by the PKS pathway was previously suggested by 
Banker et al. (2000) where it was observed that PMAs were not observed in strains of 
Aphanizomenon that no longer produced CYN (which is derived from the PKS 
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biosynthetic pathway).  Likewise, PMAs were also previously isolated from strains of 
cyanobacteria that produce CYN (e.g., A. ovalisporum) or other PKS-derived toxins (e.g., 
tolytoxin; Mynderse and Moore, 1979 and Mori et al., 1991a and 1991b). In the current 
study, PMAs were also identified from a CYN-producing strain of C. raciborskii (AQS), 
however, they were not observed in our non-CYN-producing strain of the same species 
(C. raciborskii 121-1; See Table 3.2). Further analysis of different strains of CYN-
producing cyanobacteria will need to be analyzed to assess the co-occurrence of these 
two compounds. 
 
3.2.2. Taxonomic distribution of the PMAs 
In order to determine the distribution of PMAs, algal isolates (ninety-seven 
cyanobacteria and green algae) were analyzed for the presence of PMAs by LC-MS using 
a data-dependent scan, using the [M+Na]+ as the target ion for each of the PMAs (Table 
3.2). All three fractions (40% ethyl acetate in hexane, 100% ethyl acetate and 100% 
methanol) were screened for the presence of the PMAs with the PMAs being found in the 
40% ethyl acetate in hexane fraction, including fractions from APH and CAQS which 
were used as controls to confirm that the methods for fractionation and MS analysis were 
successful in identifying the PMAs. PMAs were identified in the 40% ethyl acetate 
fraction.  
From the data-dependent screening of the isolates, PMAs were observed in eight 
isolates which included both cyanobacteria and green algae. Cyanobacterial isolates 
identified to produce PMAs are Anabaena 66-2 (PMA 3), Microcystis 81-11 (PMA 3), 
Nostoc 23-2 (PMAs 2-5), and Pseudanabaena 108-1 (PMAs 2-3), all of which belong to 
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the order Nostocales with the exception of Microcystis which belongs to the order 
Chroococcales. Green algae isolates in which PMAs were identified are Pediastrum 104-
6 (PMA 2), Scenedesmus 3-4 (PMAs 2-5), Scenedesmus 79-1 and 80-15 (PMAs 2-3). 
Previously, PMAs were isolated from cyanobacterial strains belonging to the order 
Nostocales (Mynderse and Moore, 1979; Mori et al., 1991a and 1991b; Banker et al., 
2000), however from this current screening, the PMAs seemed to be more widespread 
being found in Microcystis (Order Chroococcales) and green algae, a different organism 
than cyanobacteria.  
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Table 3. 2: Screening of cyanobacterial and green algal extracts for the presence of PMAs analyzed by LC-MS in data-dependent scan mode. 
PMAs were determined based on retention times and m/z of the [M+Na]+ ions. 
Cyanobacterial Isolates 
Polymethoxy-1-alkenes  
Cyanobacterial Isolates 
Polymethoxy-1-alkenes 
1 2 3 4 5 6  1 2 3 4 5 6 
              
Aphanizomenon X X X X X X  Microcystis 95-11      
Cylindrospermopsis AQS X X X X X X  Microcystis 95-12     
        Microcystis 95-13       
Arthronema 63a-5         Microcystis 95-4       
Amatoidea/Calothrix 70-1        Microcystis 99-1       
Anabaena 48-2        Nostoc 15-7b     
Anabaena 66-2   X     Nostoc 23-2  X X X X  
Anabaena S12        Nostoc 23-2a-1       
*Ankistrodesmus 45-2        Nostoc 64-15       
Aphanothece 103-7        Nostoc EV-1        
Aphanothece 104-9        Nostoc S2       
Arthronema 37-8-1        Oscillatoria 101-1A8       
Arthronema 63-1       Oscillatoria 21-9-3       
Arthronema 95-2a        *Pediastrum 104-6   X    
Calothrix 13-3        Phormidium 49-1       
Calothrix 30-3        Phormidium 62-2       
Calothrix 3-26        Phormidium 64-13       
Calothrix 3-27        Phormidium 69-9       
Calothrix 33-2        Plectonema 33-7       
Calothrix 67-1        Pseudanabaena 108-1  X X    
*Coelastrum 104-10        Pseudanabaena 81-4       
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Cyanobacterial Isolates 
Polymethoxy-1-alkenes  
Cyanobacterial Isolates 
Polymethoxy-1-alkenes 
1 2 3 4 5 6  1 2 3 4 5 6 
Cyanosarcina 33-3        Pseudanabaena 95-13a     
Cylindrospermopsis 121-1        Pseudoanabaena 69-7       
Dictiospherium 107-2        Pseudoanabaena 73-2       
Fischerella 114-12        Pseudocapsa 64-17      
Fischerella 114-4        *Scenedesmus 3-4  X X X X  
Fischerella 52-1        *Scenedesmus 79-1  X X    
Fischerella 52-1        *Scenedesmus 80-15  X X    
Gleocapsa 30-1-5        Scytonema 26-1       
Gleocapsa 37-8        Scytonema 26-1       
*Kirchneriella 104-2        Spirulina 21-0       
Leptolyngbya 102c-1         Synechococcus 103-5       
Leptolyngbya 30-1-2        Synechococcus 21-10a       
Leptolyngbya 69-2        Synechococcus 21-11       
Leptolyngbya 69-5        Synechococcus 84-2a       
Leptolyngbya 71-2        Synechococcus 22-1       
Limnothrix 16-1        Synechococcus 47-1       
Limnothrix 21-2-2        Synechococcus 47-1       
Limnothrix 39-1        Synechococcus 71-3       
Limnothrix 48-1        Synechococcus 74-1       
Limnothrix 60-1        Synechocystis 104-3        
Lyngbya 105-2        Synechocystis 108-7        
Lyngbya 15-2        Synechocystis 63a-2       
Lyngbya 29-3        Synechocystis 79-3      
Microcystis 22-6        Synechocystis 84-1       
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Cyanobacterial Isolates 
Polymethoxy-1-alkenes  
Cyanobacterial Isolates 
Polymethoxy-1-alkenes 
1 2 3 4 5 6  1 2 3 4 5 6 
Microcystis 36-1        Tolypothrix 30-1-4       
Microcystis 75-1        Tolypothrix 30-1-40       
Microcystis 81-11   X     Tolypothrix 38-6       
Microcystis 84-2        Tolypothrix 64-11       
Note: Isolates with an asterisk (*) are green algae and the isolates in bold are those from which PMAs have been purified. 
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3.3. Methods 
3.3.1. 1-13C-labeled acetate feeding experiments 
The polymethoxy-1-alkenes have slight resemblance to polyketides synthesized by 
the polyketide-synthase mechanism. As such, this hypothesis was evaluated by doing a 
feeding experiment with 1-13C-labeled acetate and evaluated for incorporation of 13C in 
the molecules. Cyanobacterial cultures (APH and CAQS) were grown in 3L flasks in 
BG11 medium under cool-white fluorescent light (intensity 30µEm-2sec-1) with constant 
aeration (Gantar et al., 2008). For feeding experiments, an actively growing culture of 
CAQS was sub-cultured (see Section 2.3.1. Culturing of Cyanobacteria), and on days 2, 
9, 16 and 23 supplemented with 500 mg of 1-13C-labeled acetate; cultured material was 
harvested on day 25. 
 
3.3.2. Purification of 1-13C-labeled PMAs and Chemical Characterization 
Purification of the PMAs was carried out as before using the silica-gel column, 
with the 100% ethyl acetate fraction containing the labeled PMAs. Two HPLC 
purifications were performed to purify the PMAs; first with an increasing gradient of 
acetonitrile in water followed by an isocratic elution of 65% acetonitrile with each PMA 
being individually collected for chemical characterization. Mass spectral data was 
obtained by LC-MS using a HESI source. To determine the percentage enrichment of 13C 
in the PMAs, NMR experiments (specifically inverse-gated decoupled 13C) were carried 
out and compared to those of the unlabeled PMAs. 
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3.3.3. Preparation of cyanobacterial extracts for PMA screening 
Ninety-seven algal isolates were obtained from a culture collection (obtained from 
Dr. Miroslav Gantar, FIU) and prepared based on the isolation of the PMAs. Isolates 
were extracted twice in chloroform, using the freeze-thaw method to break open the cells. 
The samples were filtered and the extracts (supernatant) were dried down and re-
suspended in 1mL of chloroform. Extracts were fractionated using solid-phase extraction 
(SPE) cartridge (Supelclean LC-Si SPE Tubes, bed weight 100mg, volume 1mL) and 
three fractions were collected; 40% ethyl acetate in hexane, 100% ethyl acetate, and 
100% methanol, with LC-MS analysis being done on all three fractions. 
 
3.3.4. Mass spectrometric analysis of the occurrence of PMAs 
All 3 fractions of the cyanobacterial isolates from the SPE were analyzed for the 
presence of PMAs by LC-MS on a reversed-phase column (Phenomenex Kinetex 2.6 μm 
C18 100 Å LC Column 100 × 4.6 mm).  The fractions were analyzed using an acetonitrile 
gradient starting with 50% acetonitrile in water for 5mins with an increasing gradient up 
100% acetonitrile over 15mins and kept at 100% acetonitrile for 5mins for a total run 
time of 25mins. A data-dependent MS analysis was done using electrospray ionization 
(ESI), and the retention times and masses were evaluated for the presence of PMAs using 
APH and CAQS as controls. 
 
3.4. Conclusion 
Analysis of the results from the feeding experiments testing the hypothesis that the 
biosynthesis of the PMAs occurs via the PKS biosynthetic pathway were inconclusive, 
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however there is some suggestion of a possibly different mechanism for the biosynthesis. 
The MS analysis indicates that there is incorporation of the 13C-labeled acetate, 
suggesting a PKS biosynthetic route, however NMR analysis showed that incorporation 
was seen throughout the entire molecule which is not consistent with the pattern of a PKS 
biosynthetic route. It can be however be concluded that these compounds were 
synthesized by the cultured organism. Further analysis is required to identify how the 
labeled acetate is being incorporated into the compounds. 
PMAs were previously thought to be produced by cyanobacteria in the order of 
Nostocales. Results have shown that not only are they produced by many different genera 
of cyanobacteria (terrestrial, marine, and freshwater), they are also produced by green 
algae. This indicates that these molecules are widely produced in different environments, 
as well as from different organisms. These compounds may therefore contribute to the 
toxicity of cyanoHABs and other symbiotic organisms in various environments. 
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CHAPTER 4* 
 
ASSESSMENT OF THE TOXICOLOGICAL EFFECTS OF POLYMETHOXY-1-
ALKENES FROM APHANIZOMENON OVALISPORUM USING THE ZEBRAFISH 
EMBRYO BIOASSAY 
 
*A portion of the work described in this chapter has been published in the journal, 
Marine Drugs (Jaja-Chimedza et al., 2012). 
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4.1. Introduction 
In several previous studies (Berry et al., 2004; Berry et al., 2007; Berry et al., 
2009; Walton et al., in preparation), we have utilized the zebrafish (Danio rerio) embryo, 
as a model of vertebrate development, and specifically a toxicological (i.e. bioassay) 
system, to investigate “developmental toxicity” (i.e. inhibition or impairment of 
developmental pathways) of cyanobacterial secondary metabolites. The zebrafish embryo 
has become an increasingly important vertebrate model owing to a number of practical 
advantages including: a high fecundity capable of producing hundreds of eggs with a 
single breeding; rapid embryonic development with most internal organs being fully 
differentiated by 96 hours post fertilization (hpf); as well as a nearly transparent outer 
chorion allowing for development to be easily monitored using a light microscope (Berry 
et al., 2007). As such, this model system is finding utility in fields ranging from genetics 
to toxicology/pharmacology to biotechnology (Teraoka et al., 2003; Hill et al., 2005). In 
prior studies (Berry et al., 2004; Berry et al., 2007; Berry et al., 2009), the zebrafish 
embryo assay has been specifically applied to identification (i.e screening), purification 
(i.e. bioassay-guided fractionation) and characterization of developmental toxins from 
cyanobacteria.   
As part of this on-going research, Berry et al. (2009) previously evaluated the 
hepatotoxin, cylindrospermopsin (CYN), as well as extracts from unialgal cultures of 
several CYN producing and non-producing strains of the widespread toxigenic 
cyanobacterial species, Cylindrospermopsis raciborskii and Aphanizomenon 
ovalisporum.  Although CYN was found to be toxic, apparent impermeability of the 
embryonic chorion and/or cellular membranes, with respect to the water-soluble toxin, 
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necessitated microinjection of the pure compound for toxicity to be observed.  In fact, a 
similar apparent impermeability – and requirement for microinjection – was, likewise, 
observed for the equally water-soluble microcystins (Wang et al., 2005). Moreover, 
toxicity of microinjected CYN was generally only associated with a dose-dependent 
increase in mortality of embryos, but no clear or reproducible developmental dysfunction 
(Berry et al., 2009).  In contrast, however, concurrent evaluation of crude, non-polar (i.e. 
chloroform) extracts from strains of both C. raciborskii and A. ovalisporum identified 
developmental toxicity, clearly unrelated to the presence of CYN, and specifically 
associated with apparent lipophilic metabolites from extracts of all of the isolates 
evaluated (Berry et al., 2009). 
Toward understanding the possible contribution of these apparent lipophilic 
metabolites to the toxigenicity of these cyanobacterial species, the present study used the 
zebrafish embryo bioassay to guide purification for subsequent chemical and 
toxicological characterization of the previously identified (Berry et al., 2009) 
developmental toxin(s) from one of these isolates.  Indeed, in the present study, bioassay-
guided fractionation, as previously described, led to the isolation, and chemical 
characterization of these previously identified polymethoxy-1-alkenes (PMAs), i.e. 4-6, 
as well as three additional members (1-3) of the apparent homologous series (Figure 2.1), 
as lipophilic developmental toxins from the Lake Kinneret strain of A. ovalisporum.  
Although three of the six PMAs reported here have been isolated previously from this 
strain (Banker et al., 2000) - as well as at least two other genera (i.e. Scytonema, 
Tolypothrix) of the cyanobacterial order Nostocales (Mynderse and Moore, 1979; Mori et 
al., 1991a and 1991b) – in studies spanning more than three decades, they have not 
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previously been associated with toxicity.  We report here on their developmental toxicity 
in the zebrafish embryo model, and specifically the apparent synergistic activity of 
congeners in the series. 
 
4.2. Results & Discussion 
Crude extracts containing PMAs and purified PMAs (1-5) from both strains of 
PMA-producing cyanobacteria were tested using the zebrafish embryos to have a better 
understanding of its toxicological effects. Additional bioactivity was evaluated using 
other bioasssays include mosquito larvicidal bioassay, cytotoxicity assay and antibacterial 
assay.  
 
4.2.1. Zebrafish Embryo Bioassay 
Although previously isolated from A. ovalisporum (Banker et al., 2000), and 
several other cyanobacterial species (Mynderse and Moore, 1979; Mori et al., 1991a and 
1991b), PMAs have not been previously associated with toxicity or other bioactivity. 
Indeed, Mynderse and Moore (1979) first isolated the isotactic PMAs, including 2, 3 and 
4, as components of “non-toxic mixture,” while looking for the cytotoxic polyketide, 
tolytoxin A. As such, the present study is the first report of the biological activity of the 
PMAs. It should, however, be noted that a parallel series of polymethoxydienes isolated 
from the marine sponge, Myriastra clavosa, were found to be moderately cytotoxic to a 
human colon cancer cell-line, and suggested in fact, based on chemical similarity, to be 
derived (via diet and metabolic transformation) from cyanobacteria (Rao and Faulkner, 
2002). 
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Individual PMAs: In the current study, five of the six PMAs (1-5) were obtained in 
sufficient (i.e., accurately weighable) quantities, and subsequently evaluated for 
developmental toxicity in the zebrafish embryo model. Zebrafish embryos, exposed (five 
embryos per concentration) to a representative concentration range (10, 25, 50 and 100 
μg mL-1) of 1-5, were observed up to five days post-fertilization (dpf) for mortality and 
apparent developmental dysfunction. It should be noted that solubility, and consequently 
the absolute dissolved concentration, of PMAs in aqueous assay medium remains 
uncertain; however, the assumption of relatively low water-solubility of these lipophilic 
compounds would suggest that prepared exposure concentrations may, in fact, 
overestimate actual dissolved exposure concentrations. 
Notably, toxicity of PMAs in the zebrafish embryo assay seemed to correlate with 
chain length and/or associated degree of methoxylation of the variants. With regards to 
embryo mortality (Table 4.1), no effect was observed at the lowest exposure 
concentrations (10 and 25 μg mL-1) for any of the variants tested. In a typical experiment, 
however, 100% mortality at 5 dpf was observed for embryos exposed to both 50 and 100 
μg mL-1 of the three smallest congeners (1-3), whereas relatively little (i.e., 20%-40%) or 
no mortality for the same doses were observed for embryos exposed to the two 
increasingly larger congeners (i.e., 4 and 5, respectively) tested. For comparison, 
mortality in untreated controls was very low (i.e., approximately 1.7%, n = 60 embryos). 
Similarly, there was an apparently parallel, congener-dependent effect on hatching rates 
(Table 4.1). Again, little or no effect on hatching (i.e., 80%-100% hatching rate at 4 dpf; 
n = 5 eggs) was observed for lowest exposure concentrations (10 and 25 μg mL-1) of any 
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of the PMAs tested relative to the untreated controls (98% hatching, n = 60 eggs). 
However, the hatching of embryos was inhibited by PMAs in a dose- and congener-
dependent manner at the two highest exposure concentrations (50 and 100 μg mL-1). 
Specifically, hatching (4 dpf) was completely inhibited in embryos exposed to 100 μg 
mL-1 of congeners 1-3, but only partially inhibited for embryos exposed to 4, and not 
appreciably affected in embryos exposed to the largest variant tested (5). Supporting a 
dose and congener dependent effect, at 50 μg mL-1 hatching was completely inhibited by 
only the two smallest congeners (1 and 2), and decreasingly affected by the larger 3-5. 
These observations were further supported by a preliminary evaluation of 3-5, which 
were initially purified in sufficient quantities to test. This preliminary exposure study 
showed a similar pattern to that reported in Table 4.1 for these congeners, with 3 causing 
100% mortality as well as gross development defects at the highest concentrations tested 
(50 and 100 μg mL-1), while 4 caused only low mortality (20%) at the highest 
concentration (100 μg mL-1) and none at lower concentrations, and 5 did not cause 
mortality at any exposure level at 5 dpf. Although little or no mortality was observed for 
embryos exposed to 4 at these highest concentrations, all surviving embryos were 
characterized by developmental dysfunction and deformity (as discussed further below); 
in contrast, no distinguishable effects on development were observed for embryos 
exposed to any concentration of 5. Thus, while the limited availability of purified 
material precluded conducting a full-scale quantitative toxicological characterization of 
the PMAs, the consistency of the trends observed strongly supports a dose and congener 
related toxicity effect on these embryos. 
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Table 4. 1: Mortality and Hatching Rates for Zebrafish Embryos Exposed to PMAs (1-5) from A. 
ovalisporum (Lake Kinneret, Israel). Mortality was recorded at five days post-fertilization (dpf) 
for five embryos per concentration. Hatching rates were recorded at 4 dpf. 
 % Mortality (5 dpf) b Hatching Rate (4 dpf) b 
PMA 
aConc.: 
 
10 
 
25 
 
50 
 
100 
 
10 
 
25 
 
50 
 
100 
1 20% 0% 100% 100% 100% 100% 0% 0% 
2 0% 0% 100% 100% 100% 80% 0% 0% 
3 0% 0% 100% 100% 100% 80% 40% 0% 
4 0% 0% 40% 20% 100% 100% 60% 60% 
5 0% 0% 0% 0% 100% 100% 80% 80% 
a Concentration of PMAs tested at 10, 25, 50 and 100 μg mL-1; b In treated wells n = 5 and in 
untreated controls, mortality was approximately 1.7%, while hatching rate was 98% (n = 60 
embryos). 
 
In addition to the effects on mortality and hatching rate, there was also an 
apparent correlation between both exposure dose and structural variation of the PMAs 
(i.e., degree of methoxylation, chain length) and observed morphological developmental 
effects (Figure 4.1). At the highest concentration tested (100 μg mL-1), embryos exposed 
to the smallest congener (1) exhibited several indications of severely impaired 
development (Figure 4.1E), including near lack of pigmentation, impaired organogenesis 
(e.g., reduced eye formation), deformity of the yolk sac and other gross abnormalities. 
Although developmental effects were less profound for congeners 2 and 3 at the same 
exposure concentration (100 μg mL-1), embryos exposed to both of these larger variants 
were also characterized (Figure 4.1F,G, respectively) by similar defects as well as the 
formation of edemas (along with reduced hatching rates; see above). Developmental 
dysfunction was uniformly observed (i.e., 100% of embryos), although the severity of 
this dysfunction varied, and in each case, was followed by embryo mortality within 5-6 
dpf. In contrast, embryos exposed to the highest dosage of congener 4 showed relatively 
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limited developmental effects (e.g., slightly curved body axes; Figure 4.1H) and those 
exposed to 5 were indistinguishable (data not shown) from untreated controls (Figure 
4.1I). Development was also inhibited and abnormal in all embryos exposed to a lower 
concentration (50 μg mL-1) of 1-3, but there was no clear correlation of prevalence or 
severity of defects with congener size. (Figure 4.1A-C). However, similar to the effects 
observed at the higher concentrations, there were clearly minimal effects of congener 4 
(Figure 4.1D) and no detectable effects associated with 5. One particularly notable effect 
observed was an apparent pooling of blood between the anterior surface of the yolk and 
the heart in embryos exposed to 1-3 (indicated by arrows in Figure 4.1); this was most 
obvious in embryos exposed to the lower concentration (50 μg mL-1) of all three of these 
congeners and the higher concentration (100 μg mL-1) of the largest of these variants (3). 
This effect was not observed in the more severely deformed embryos exposed to the 
highest concentration of 1 and 2, where it was likely obscured by the numerous severe 
developmental defects present in these fish. As for the assessment of mortality and 
hatching rate (see above; Table 4.1), data from a single experiment are presented, due to 
limitations of the purified PMAs. However, additional studies with a subset of these 
congeners, including both evaluation of initially purified amounts of 3-5 (as discussed 
above), and the subsequent evaluation of 3 and 4 with respect to apparent interactive 
effects (Figure 4.2; discussed below), likewise generally confirm the observed congener-
dependent trend of delayed and/or dysfunctional development. 
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Figure 4. 1: Developmental Toxicity of PMAs (1-4) Isolated from A. ovalisporum (Lake 
Kinneret, Israel). Photomicrographs of embryos at 4 dpf. Shown are embryos exposed to 1-4 at 50 
μg mL-1 (A-D, respectively) and 100 μg mL-1 (E-H, respectively). Untreated control embryo at 4 
dpf (I) shown for comparison. Arrows indicate areas where blood is pooled adjacent to the heart. 
Images in A-C and E-G, are not to scale with D, H and I. 
 
Synergistic Effects: Based on the qualitatively more pronounced developmental 
toxicity observed during bioassay-guided fractionation compared to that of individual 
congeners, we evaluated pair-wise combinations of 3 and 4 - as two of the most abundant 
variants (i.e., purified in the largest quantity) with the latter showing only relatively 
limited toxicity - in order to assess possible synergistic and/or additive effects of the 
PMAs. Interestingly, a clear interactive effect of the congeners, in terms of embryos 
toxicity, was observed for embryos exposed to a combination of two variants when 
compared to either 3 or 4, individually. Embryos exposed to 50 and 100 μg mL-1 of each 
compound were characterized by the typically moderate developmental dysfunction 
observed for these variants (Figure 4.1 and 4.2A-C). However, when exposed to 
equivalent total concentrations comprised of equal amounts congeners 3 and 4 (i.e., 25 μg 
mL-1 and 50 μg mL-1, respectively, of 3 and 4), there was a clearly more pronounced 
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inhibition of development (Figure 4.2D,E). All embryos exposed to both combined 
concentrations were characterized by a severe inhibition of organogenesis and overall 
differentiation and development of the embryo that was not observed for embryos 
exposed to any of the congeners individually at an equivalent concentration. This 
observation is consistent with a synergistic effect of these variants and may explain 
increased toxicity of PMA mixtures (when compared to individual variants). Synergistic 
interactions of biologically active cyanobacterial metabolites have been previously 
reported. Recently, for example, Leão et al. (2010) documented similar synergistic 
effects with regards to algicidal activity of the cyclic peptide congeners, portoamides A 
and B, isolated as apparent allelochemicals from a freshwater strain of Oscillatoria. 
Likewise, a similarly synergistic effect of lobocyclamides A and B, isolated from a 
marine cyanobacterial species, Lyngbya confervoides, was previously reported 
(MacMillan et al., 2002), specifically in relation to antifungal activity of these 
lipopeptides. 
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Figure 4. 2: Apparent synergistic interactions in the developmental toxicity of 3 and 4. Shown are 
embryos exposed to 50 μg mL-1 of 3 (A), and 100 μg mL-1 of 3 (B) and 4 (C), compared to an 
equivalent combined total concentration (i.e., 25 and 50 μg mL-1 of each) of the two variants (D 
and E, respectively). Embryos shown at 4 dpf. 
 
The identification of toxicity associated with the PMAs, combined with the 
previous isolation of related variants from other distantly related marine, freshwater and 
terrestrial cyanobacterial genera (Mynderse and Moore, 1979; Mori et al., 1991a and 
1991b), as well as the cyanobacterially derived polymethoxydienes found in marine 
sponges (Rao and Faulkner, 2002), suggests that PMAs may represent a relatively 
widespread toxic metabolite from the blue-green algae. Moreover, preliminary evaluation 
by LC-MS, and subsequent purification and identification (by MS and 1H-NMR), 
confirmed the presence of 1-6 in the extracellular medium of the A. ovalisporum cultures 
(data not shown), and suggests that these lipophilic metabolites may, to some degree, be 
released - either actively by excretion, or passively via senescence of algal cells - into the 
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surrounding aqueous environment. Accordingly, it is proposed that the presence of these 
lipophilic metabolites may not only contribute to previously observed toxicity associated 
with lipophilic fractions of toxigenic cyanobacteria (Berry et al., 2009), but to the 
observed toxicity of the bloom-forming cyanobacteria more generally. 
 
4.2.2. Mosquito Larvicidal Bioassay  
Mosquito larvae (Aedes aegyptii) were used to test for larvicidal activity of the 
PMAs, using both crude extracts and purified compounds. Chloroform extracts of APH 
and CAQS, and SPE fractions (40% ethyl acetate, 100% ethyl acetate, and 100% 
methanol) were tested at different doses and bioactivity was observed over a period of 8 
days. For the chloroform extracts, bioactivity was observed in doses of 10 and 50µL, with 
no bioactivity being observed at 100µL. At 10µL, 25% mortality was observed by day 3 
and 50% mortality was observed by day 5 until the end of the bioassay. At 50µL, 25% 
mortality was observed at day 5 and for the rest of the bioassay. The only SPE fraction 
that showed bioactivity was 100% ethyl acetate at 100µL where 25% mortality was 
observed from day 4 onwards. There was 3% mortality observed for the controls and the 
mortality occurred at day 6. 
For the purified PMAs, bioactivity was only observed with PMA 4 at 100µg/mL in 
both bioassays using the new and the old eggs. For the new eggs, no mortality was 
observed up to 8 days, however the larvae were slow moving and there was slightly slow 
development. At 5 days, the larvae were still at the 2nd instar stage and remained there 
until day 7 after which further development slowly continued with the larvae being 
noticeably smaller than the controls. There were no mortalities in the controls (solvent 
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and water) and development was normal. For the old eggs, 25% mortality was observed 
from day 2 to day 8. At day 3, all larvae were at the 1st instar stage and by day 5 only one 
larva was at the 2nd instar stage. By day 6, all larvae were at the 2nd instar stage with one 
larva being very early. This slow development continued throughout the rest of the 
bioassay with only one larva reaching 3rd instar by the end of the bioassay. There were no 
mortalities observed in the controls and development proceeded as normal.   
In both new and old eggs, PMA 4 only showed slight bioactivity at the highest 
concentration tested. None of the other PMAs showed any bioactivity suggesting that the 
mosquito larvae are not very susceptible to these compounds. Though there was slow 
development observed in the larvae exposed to PMA 4, there were no apparent 
developmental abnormalities. This observed slow development was slightly more 
pronounced in the old eggs than the new eggs, which is to be expected since the new eggs 
tend to be more robust than the old eggs.   
 
Table 4. 2: PMA exposures to mosquito larvicides, showing results at day 8 of the bioassay. 
 % Mortality (Instar) b 
New Eggs (2 weeks) 
% Mortality (Instar) b 
Old Eggs (2 mnths) 
PMA 
aConc.: 
 
10 
 
25 
 
50 
 
100 
 
10 
 
25 
 
50 
 
100 
1 0 (3) 0 (3) 0 (3) ND 0 (3) 0 (3) 0 (3) ND 
2 0 (3) 0 (3) 0 (3) ND 0 (3) 0 (3) 0 (3) ND 
3 0 (3) 0 (3) 0 (3) ND 0 (3) 0 (3) 0 (3) ND 
4 0 (3) 0 (3) 0 (3) 0 (2) 0 (3) 0 (3) 0 (3) 0 (2) 
5 0 (3) 0 (3) 0 (3) ND 0 (3) 0 (3) 0 (3) ND 
Note: Control larvae were at late stage 3rd instar upon termination of the bioassay. 
 
 98 
 
4.2.3. Cytotoxicity Bioassay 
Crude extracts containing PMAs were analyzed using a cell based bioassay to test 
for cytotoxicity against 3 different cell lines; PC-3, SKMEL-5, and HEPG-2. Chloroform 
extracts of APH, CAQS, and CMEX were used and the hexane extract of MC 81-11. 
Cells were dried down and resuspended in 25µL of DMSO for a total concentration of 
approximately 2% DMSO (maximum amount that the cells can withstand). No 
bioactivity was observed in the cells using any of the cyanobacterial isolates as indicated 
by the pink color from the alamar blue solution. The PMAs originally isolated showed no 
bioactivity against cell lines (Mynderse and Moore, 1979) which was also similar to what 
was observed for these cyanobacterial extracts containing crude mixtures of PMAs.  
 
4.2.4. Antibacterial Bioassay 
Five bacterial strains, including Gram-negative (E. coli) and Gram-positive, were 
used to identify any potential antibacterial activity with the crude cyanobacterial extracts 
known to contain the PMAs. Chloroform extracts were used for APH, CAQS, and 
CMEX, and the hexane extract of MC 81-11 against the five strains of bacteria as shown 
in the Table 4.2. Slight bioactivity was observed in the extracts from CAQS, CMEX, and 
MC 81-11 against the bacteria B. megaterium and in the CAQS extract against E. coli, 
however there was no other bioactivity observed against the other bacterial strains. No 
bioactivity was observed for the APH against any of the bacterial strains. Since no 
significant bioactivity was observed with any of the cyanobacterial isolates no further 
fractionation was performed and no further analysis was carried out. 
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Table 4. 3: Antibacterial activity of extracts of the cyanobacterial isolates using 5 different strains 
of bacteria. 
Cyanobacterial 
Isolate 
Bacterial Strain 
B. megaterium B. subtilis E. coli M. luteus S. aureus 
APH - - - - - 
CAQS + - + - - 
CMEX + - - - - 
MC 81-11 + - - - - 
 
 
4.3. Methods 
4.3.1. Zebrafish Maintenance and Breeding 
The zebrafish (Danio rerio) embryo was used as a model of developmental toxicity 
for both bioassay-guided fractionation and subsequent toxicological characterization. The 
maintenance and breeding of adult zebrafish, and the embryo toxicity bioassays, were 
carried out as previously described by Berry et al. (2004 and 2007) and according to 
protocols approved by the FIU Institutional Animal Care and Use Committee (IACUC). 
The zebrafish lines used for this experiment were obtained from Dr. Patrick Gibbs 
(University of Miami Rosenstiel School of Marine and Atmospheric Science –RSMAS; 
P4 line) and Petco Animal Supplies Inc. Adult zebrafish (males and females) were 
maintained in tanks with dechlorinated tap water (treated with Amquel) at 26 ± 0.5oC on 
a diet of fish flakes and brine shrimp. The zebrafish were subjected to a light/dark cycle 
of 14h/10h with mating and spawning occurring at the beginning of the light cycle.  
For breeding, about 10-20 male and female zebrafish were placed above a mesh 
enclosure in a 10-L tank within 15 minutes of the onset of the light cycle. Upon 
successful breeding, the fertilized eggs would fall through the mesh and settle at the 
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bottom of the tank where they could be collected. After the eggs were collected, they 
were rinsed fish water and subsequently placed in a Petri dish with E3 medium 
containing methylene blue (5mM NaCl, 0.17mM KCl, 0.33mM CaCl2, and 0.33mM 
MgSO4: Brand et al., 2002). Unfertilized and poor quality embryos were removed from 
the dish and the remaining embryos were subsequently used (usually within 2-3 hpf) for 
developmental toxicological studies. 
 
4.3.2. Zebrafish Embryo Bioassay (Exposure Studies) 
Toxicity was evaluated in solvent-resistant, polypropylene 24-well plates 
(Evergreen Scientific, Los Angeles, CA) with five embryos per well in E3 medium 
(Brand et al., 2002). Extracts and fractions were typically evaluated at a high- (100 μL) 
and low- (10 μL) exposure concentration, and vehicle (corresponding solvent) and 
“untreated” controls were also included in each assay. The solvent was evaporated from 
the assay plates, prior to adding medium (E3) and embryos, and accordingly there was no 
observed effect of the solvent (relative to the untreated controls). The embryos were 
observed up to 5 days post fertilization (dpf) for bioactivity. In addition to percent 
hatching and mortality, developmental toxicity was recorded by photomicrography using 
an Olympus SZX7 stereomicroscope equipped with an Olympus DP72 digital camera. 
 
Exposures with Individual PMAs: Purified PMAs were evaluated at concentrations 
of 2, 5, 10, 25, 50 and 100 μg mL-1 (in acetonitrile). Vehicle (acetonitrile-only) and 
“untreated” controls were also included with each exposure. 
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Synergism Experiments: During purification of the PMAs, there was some evidence 
to suggest that there was a synergistic relationship with the different PMAs which led to 
the development of a synergistic experiment to analyze this possibility. Only PMAs 3 and 
4 were obtained in sufficient quantities to do additional exposures and therefore were 
initially used as a preliminary assessment of synergism at individual concentrations of 10, 
25 and 50 μg mL-1 for a total concentration of 20, 50 and 100 μg mL-1 (for a total of 3 
treatments). 
 
4.3.3. Mosquito Larvicidal Bioassay 
The mosquito larvicidal bioassay was performed by Jerry Berry using the following 
protocol. Crude extracts and purified compounds were placed in 24-well polypropylene 
plates and the solvent was allowed to evaporate. The plates were then filled with newly 
hatched mosquito larvae (1st instar stage) in water using 4 larvae per well, for a total of 
1mL. Solvent controls were prepared in the same manner as the cyanobacterial samples. 
Larvae were fed daily with 30µL of a 0.1% yeast powder solution, and assessed for up to 
8 days for mortality, current instar stage, and developmental effects. 
Crude chloroform extracts of CAQS were tested at doses of 10, 50 and 100µL and 
SPE fractions (40% hexane in ethyl acetate, 100% ethyl acetate, and 100% methanol) 
using new eggs (approximately 2 weeks old). Purified PMAs (3-6) from CAQS were 
used for the mosquito larvicidal bioassay at concentrations of 10, 25, and 50µg/mL for all 
PMAs and up to 100µg/mL for PMA 4 only because it was the most abundant. Purified 
samples were tested using both new (2 weeks) and old (2 months) eggs, representing the 
wet and dry seasons respectively. 
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4.3.4. Cytotoxicity Bioassay 
The cytotoxicity bioassay was carried out using two different cancer cell lines 
obtained from American Type Culture Collection (ATCC; Virginia, USA); prostate 
cancer (PC-3), skin melanoma (SKMEL-5), and hepatoma (HEPG-6) cell lines. Cells 
were sub-cultured using RPMI medium (for PC-3 and SKMEL-5) and Eagle’s medium 
(for HEPG-6) in 96-well plates for bioassay. Exposures were carried out once the cells 
were confluent. Prepared chloroform extracts containing a mixture of PMAs were tested 
for cytotoxic activity at dosages of 0.25, 0.5, 1, and 2µL, using dimethylsulfoxide 
(DMSO) as the solvent. Cells were incubated overnight after which the medium was 
removed and replaced with 10% alamar blue in RPMI or Eagle’s medium for 4 hours to 
assess for mortality. For dead cells, the medium will remain blue, and for live cells, the 
medium will turns red/pink due to metabolism by the cells. 
 
4.3.5. Antibacterial Bioassay 
The antibacterial bioassay was carried out with five bacterial strains provided by 
Miroslav Gantar (FIU, Department of Biological Sciences); Escherichia coli, 
Staphylococcus aureus, Bacillus megaterium, Bacillus subtilis, and Micrococcus luteus. 
Liquid cultures of the bacteria were prepared using nutrient broth for the bioassay. 
Bioassays were done using the disc-diffusion method, using 6mm discs. Chloroform 
extracts of APH and CAQS were applied to the discs (30µL) and the solvent was allowed 
to evaporate before placing on the agar plate. Negative controls (solvent only) and 
positive controls (neomycin at 0.1 and 0.5mg/mL) were also carried out. Liquid cultures 
(approximately 1mL) were placed on the agar plates and dispersed for full coverage. 
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Discs containing the samples and the controls were then placed on the plates which were 
left to incubate overnight, and subsequently observed for inhibition of growth. 
 
4.4. Conclusion 
In the present study, the zebrafish embryo model was used to evaluate the 
toxicological effects of a homologous series (Figure 2.1) of isotactic PMAs which are 
toxic components of the lipophilic fraction of the Lake Kinneret isolate of A. 
ovalisporum.  Although, toxicological evaluation of these compounds was somewhat 
limited by availability of purified amounts of the toxins - particularly given the relatively 
low solubility/activity, and high exposure concentrations required, for the individual 
congeners - our initial studies suggest both a dose-dependent toxicity relationship (Figure 
4.2) and a relationship between toxicity in the zebrafish embryo model and structural 
variations (i.e. chain length, degree of methoxylation) of the congeners.  Moreover, 
evaluation of the interactive effects indicates a possible synergism between variants with 
enhanced developmental toxicity (Figure 4.3) observed for pair-wise combinations of the 
PMAs (e.g. 3 and 4).  
This is the first report of the PMAs as toxic or otherwise bioactive metabolites. It 
is, accordingly, suggested that these metabolites may not only explain previously 
observed developmental toxicity (Berry et al., 2009) of lipophilic fractions from A. 
ovalisporum, but that these previously unrecognized (as toxic) components may 
contribute to the overall toxicity of this CYN-producing bloom species, and the 
cyanobacteria perhaps more generally.  Indeed, the prior isolation of these compounds 
(albeit as non-toxic metabolites) from other cyanobacterial species (Mynderse and 
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Moore, 1979; Mori et al., 1991a and 1991b; Banker et al., 2000; Rao and Faulkner, 
2002), and current identification of these compounds in additional strains of 
cyanobacteria and also isolates of green algae suggests that these toxic metabolites are 
relatively widespread, and not only within the cyanobacteria.  As such, these compounds 
contribute to the toxicity of cyanoHABs as well as green algal blooms.  
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CHAPTER 5 
 
BIOACTIVE CAROTENOIDS FROM CYLINDROSPERMOPSIS RACIBORSKII AQS 
INHIBIT VERTEBRATE DEVELOPMENT IN ZEBRAFISH (DANIO RERIO) 
EMBRYOS 
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5.1. Introduction 
  Carotenoids are pigmented organic compounds which are found in many plants and 
other photosynthetic microorganisms such as algae, fungi, and also cyanobacteria. 
Carotenoids are generally thought to have two major roles in photosynthetic organisms; 
light harvesting for photosynthesis (via the transfer to chlorophyll) and prevention of 
photooxidative damage (Paerl, 1984; Hirschberg and Chamovitz, 1994). They can be 
commonly found in the membranes, making up an integral part of the complex structure 
of the membrane.  
Many of the carotenoids are typically composed of a C-40 hydrocarbon backbone 
(eight isoprenoid units), biosynthesized via the tail-to-tail attachment of two C-20 
geranylgeranyl diphosphate molecules. Extension of this C-40 backbone can occur, 
forming C-45 and C-50 carotenoids and the backbone can also be shortened, forming 
apocarotenoids of various lengths. The hydrocarbon backbone can also be modified by 1) 
cyclization of one of both ends of the molecule, 2) changes in the level of hydrogenation, 
and 3) incorporation of oxygen into functional groups (reviewed by Britton, 1995). As 
such, carotenoids can be divided into two classes; carotenes (which contain only 
hydrogen and carbon) and xanthophylls (which contain hydrogen, carbon, and oxygen).  
One of the most characteristic structural features of carotenoids is the long series of 
conjugated double bonds along the polyene chain which gives rise to their light-absorbing 
properties and hence their corresponding colors, which ranges from yellow to red. Each 
double bond within the hydrocarbon chain of the carotenoid molecule can exist in the cis 
or trans configuration, with the cis configuration being less thermodynamically stable 
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due to steric hindrance between the methyl groups and the hydrogen atoms. In nature, 
most carotenoids typically occur in the all-trans configuration (Britton, 1995). 
Carotenoids, when isolated, are very unstable molecules that readily undergo 
oxidation and isomerization when exposed to oxygen, heat, light, or acids after 
extraction. It has been observed that carotenoids tend to undergo isomerization in extracts 
containing chlorophyll and also when stored in acetone and exposed to light. In vivo, 
carotenoids are much more stable than when isolated because they are stabilized by 
proteins and other molecules. However if they come in contact with oxidizing species or 
free radicals, they are still susceptible to oxidative damage in vivo, but to a considerably 
lesser degree. Accordingly, great care must be taken during the extraction and isolation of 
these compounds to prevent their decomposition. The most favorable conditions usually 
involve working in dimly lit environments and keeping the samples dry and under inert 
conditions. 
 
5.1.1. Carotenoids from Cyanobacteria 
Cyanobacteria are one of the oldest known photosynthetic organisms and are 
therefore known to contain many pigments including chlorophyll, carotenoids, and other 
accessory pigments which are involved in photosynthesis. In cyanobacteria, carotenoids 
are found as major pigments in the thylakoid membrane, cytoplasmic membrane, and 
outer membrane. They are commonly found as complexes with proteins. In the 
thylakoids, they are bound to important membrane proteins that are a part of the reaction 
center involved in photosynthesis, where they are involved in photoprotection (Vermaas 
et al., 2008). In a Synechocystis sp. strain of cyanobacteria (PCC 6714), it was found that 
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the carotenoids are found in the outer membrane of the cell wall with the more polar 
carotenoids such as myxoxanthophyll, other carotenoid-glycosides and zeaxanthin are 
major components of the cell wall, while the more non-polar carotenoids such as β-
carotene and echinenone are the minor components (Jurgens and Weckesser, 1985). For 
carotenoid-glycosides (specifically myxoxanthophyll), it was determined that one 
molecule of carotenoid spans the one monolayer of outer membrane with the sugar 
moiety acting as the polar head (Hirschberg and Chamovitz, 1994). 
The carotenoids produced by cyanobacteria are thought to be the same as those 
produced in plants with the exception of some xanthophylls that are unique to 
cyanobacteria such as 2-hydroxy-derivatives, ketocarotenoids, and glycosidic 
carotenoids. Ketocarotenoids and glycosidic carotenoids are thought to be unique in 
nature, especially within photosynthetic organisms (Britton et al., 2004). Figure 5.1 
shows carotenoids that are commonly found in cyanobacteria include -carotene, 
zeaxanthin, echinone, canthaxanthin, and myxoxanthophyll, with echinenone being found 
only in cyanobacteria (Hirschberg and Chamovitz, 1994). Table 5.1 below lists the 
different carotenoids that are found in cyanobacteria and the genera in which they have 
been found.  
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Myxoxanthophyll 
 
 
 
Oscillaxanthin 
 
Figure 5. 1: Chemical structures of some carotenoids commonly found in cyanobacteria. 
 
There is a wide variation in the composition of carotenoids found in cyanobacteria 
which may be due to the occurrence of the specific genes and pathways involved in the 
biosynthesis of the carotenoids. It is well know that the composition of carotenoids within 
the cyanobacteria is dependent on the growth conditions which includes growth stage, 
light intensity, source and concentration of nitrogen in the cultures. It is also dependent 
on the strain type within a given species (Takaichi and Mochimaru, 2007). 
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Table 5. 1: Commonly occurring carotenoids in cyanobacteria with their maximum absorption (λmax) and spectral fine structure (%III/II) 
Carotenoids Cyanobacterial Genera λmax/nm (solventa) # of CDB %III/II (Sa) 
-carotene Chlorogloea, Oscillatoria 439, 461, 491 (A) 11 40 (H), 35 (E) 
-carotene Anabaena, Aphanizomenon, Aphanothece, Arthrospira, 
Calothrix, Chlorogloea, Coccochloris, Cylindrospermum, 
Mastigocladus, Merimopedia, Microcoleus, Microcystis, 
Nostoc, Oscillatoria, Phormidium, Spirulina, 
Synechococcus, Tolypothrix 
429, 452, 478 (A) 11 25 (M) 
Astaxanthin Anabaena, Aphanizomenon, Calothrix, Cylindrospermum, 
Nostoc, Oscillatoria, Phormidium, Synechococcus, 
Tolypothrix 
480 (A) 13 single 
spectrum 
Caloxanthin Aphanothece, Arthrospira, Calothrix, Chlorogloea, 
Nostoc, Phormidium, Synechococcus 
426, 449, 475 (E) 11 32 (M) 
Canthaxanthin Anabaena, Aphanizomenon, Calothrix, Chlorogloea, 
Merimopedia, Microcystis, Nostoc, Oscillatoria, 
Phormidium, Spirulina, Synechococcus, Tolypothrix 
474 (E) 13 single 
spectrum 
-cryptoxanthin Anabaena, Aphanothece, Arthrospira, Chlorogloea, 
Mastigocladus, Merimopedia, Microcystis, Oscillatoria, 
Phormidium, Spirulina, Synechococcus 
428, 450, 478 (E) 10 25 (H) 
Echinenone Anabaena, Aphanizomenon, Aphanothece, Arthrospira, 
Calothrix, Chlorogloea, Coccochloris, Cylindrospermum, 
Mastigocladus, Merimopedia, Microcoleus, Microcystis, 
Nostoc, Oscillatoria, Phormidium, Spirulina, 
Synechococcus, Tolypothrix 
460 (A) 12 single 
spectrum 
Nostoxanthin Aphanothece, Calothrix, Chlorogloea, Phormidium, 
Nostoc, Synechococcus 
428, 450, 478 (E) 11 31 (M) 
Oscillaxanthin Arthrospira, Chlorogloea, Microcystis, Oscillatoria 464, 491, 525 (M) 13 40 (M) 
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Zeaxanthin Anabaena, Aphanizomenon, Aphanothece, Arthrospira, 
Calothrix, Chlorogloea, Coccochloris, Cylindrospermum, 
Mastigocladus, Merimopedia, Microcystis, Nostoc, 
Oscillatoria, Phormidium, Spirulina, Synechococcus, 
Tolypothrix 
424, 449, 476 (P) 11 25 (P) 
Myxol 2’-
glycoside 
(Myxoxanthophyll) 
Anabaena, Aphanizomenon, Aphanothece, Arthrospira, 
Calothrix, Chlorogloea, Coccochloris, Cylindrospermum, 
Mastigocladus, Merimopedia, Microcoleus, Microcystis, 
Nostoc, Oscillatoria, Phormidium, Spirulina, 
Synechococcus, Tolypothrix 
450, 478, 510 (A) 
446, 472, 502, (M) 
12 55(M), 57(A) 
Aphanizophyll Aphanizomenon, Microcystis, Oscillatoria, Anabaena 450, 476, 507 (A) 12 57 (A) 
4-Keto-myxol-2’ 
methylpentoside 
Anabaena, Oscillatoria, Synechococcus    
aSolvents: P- petroleum ether, H-hexane, E-ethyl acetate, A-acetone, M-methanol 
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5.2. Results and Discussion 
5.2.1. Isolation of the Carotenoids  
The zebrafish embryo bioassay was used to guide the purification of two bioactive 
compounds from the methanol fraction of C-AQS, both of which were pigments. The 
10% methanol fraction obtained from the silica-gel column was subjected to RP-18 SPE 
(Extract-CleanTM SPE C18-HC 10000 mg/75mL) with the bioactive fraction eluting in 
95% methanol in water with the resulting fraction have a red color. Further purification 
was done on the HPLC with a PDA detector (Prominence SPD M20A; scanning the 
wavelengths from 200-700 nm) using an isocratic solvent system of 65% acetonitrile in 
water, where the peaks were individually collected and tested on the zebrafish embryos. 
The two peaks determined to be bioactive were observed at retention times of 6.68mins 
(peak 1, which was red) and 8.59 mins (peak 2, which was orange) (Figure 5.2) and were 
shown to cause inhibition of development in the zebrafish embryos. Other peaks were 
identified in the fraction which seemed to be related to the bioactive peaks based on the 
UV-vis spectrum; however no bioactivity (using the zebrafish embryos) was observed 
with these peaks. Further analysis indicated that these peaks were the cis carotenoids 
corresponding to the trans carotenoids isolated. 
The bioactive peaks identified were individually collected and dried (under 
vacuum) for chemical characterization. During the drying process, heat was applied to a 
portion compound 1, which resulted in a loss of color to the sample, however the 
remaining portion was dried without heat and these samples were kept separate. 
Carotenoids are known to be very unstable and readily undergo decomposition when 
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exposed to oxygen, heat, light, or acids after extraction. The typical indication for the 
decomposition of the carotenoids is bleaching (loss of color). As such, it is thought that 
the sample that was gently heated during the drying process underwent decomposition as 
a result of its loss of color. It is therefore imperative to take the necessary precautions 
during extraction and analysis of carotenoids to prevent the transformation of these 
compounds.  
a) 
 
 
b) 
 
 
Figure 5. 2: a) HPLC Chromatogram of the bioactive fraction from the SPE cartridge showing the 
two bioactive peaks at retention times of 6.68 mins (1) and 8.59 mins (2) and b) UV-Vis spectra 
of the bioactive peaks from the chromatogram. 
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5.2.2. Chemical Characterization of the Carotenoids from C. raciborskii AQS 
  The first steps in the identification of carotenoids usually involves the 
chromatographic behavior and the UV-visible spectra which are distinctive for the 
carotenoids present. The chromatographic behavior gives information about the polarity 
of the carotenoids and the UV-vis absorption spectra gives important information about 
the maximum absorption (max) and the spectral fine structure. The UV-vis spectra for 
many carotenoids usually shows three distinct peaks with maximum absorptions (λmax) 
between 420-520 nm which can be shifted depending on the number of conjugated 
double bonds and conjugated cyclization within the structure. Substituents such as 
hydroxyl groups, methoxy groups, non-conjugated rings, and non-conjugated carbonyl 
groups have little or no effect on the λmax. This three-peak spectrum is highly indicative 
of a carotenoid and can be used to assist in the determination of the number of conjugated 
double bonds within the structure. The spectral fine structure (usually expressed as 
%III/II) is an indication of the shape of the spectra which is also characteristic of the 
chromophore and can be affected by the cyclization within the structure. The spectral fine 
structure reaches its maximum when the number of conjugated double bonds (N) is eight 
and decreases as it moves away from eight within the non-conjugated β-ring structure 
(Takaichi and Shimada, 1992). The %III/II is calculated by diving the height of the 
longest wavelength peak by the height of the middle wavelength peak (taking the 
minimum between the two as the baseline) and multiplying by 100. 
For peak 1, the max which was observed in 65% acetonitrile in water, was 321, 
449sh, 480, and 509 nm which, in conjunction with the color of the compound (red), 
indicates the possibility of the compound being a carotenoid. The three-peak spectrum 
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observed was %III/II was determined to be 12% (Appnedix 5.1A), however this was 
difficult to determine because the trough between the two peaks was very shallow. This is 
usually indicative of a carotenoid with conjugated carbonyl group and in some case only 
shows a single peak and the λmax is usually hard to determine (Takaichi and Shimada, 
1992). For peak 2, the max which was also observed in 65% acetonitrile in water, was 
295, 368, 450, 478, and 509 nm which, again with the color of the compound, also 
suggested that the compound is a carotenoid. The three-peak spectrum for this compound 
was 450, 478, and 509 nm from which the %III/II was determined to be 58% as shown in 
Figure 5.3. Based on the %III/II and the max observed, these compounds were suggested 
to be carotenoids, more specifically as derivatives of γ–carotene, which are well-known 
to be produced by cyanobacteria (Hirschberg and Chamovitz, 1994).   
 
Figure 5. 3: Determination of the spectral fine structure (%III/II) for peak 2. 
 
 
Mass spectrometric analysis (Figure 5.4) of the bioactive peak at retention time of 
6.68 mins (1) from the HPLC showed m/z of 744.4 determined to be M+ peak and a m/z 
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of 767.4 for the [M+Na]+ peaks. High resolution analysis gave an accurate mass of m/z 
744.4548 corresponding to a molecular formula of C46H64O8 and having a ring and 
double bond equivalent of 15 which correlates with the observed UV-Vis spectra. A 
fragment peak was also identified at m/z of 581.4 giving a loss of m/z 163. The fragment 
at m/z 581.4 could correspond to a myxol, which is a γ-carotene derivative, suggesting 
that the loss of m/z 163 corresponds to a methylpentoside indicating that the suggested 
carotenoid (m/z 744) is a myxol derivative with a glycosidic functional group. 
Fragmentation of both the molecular ion peak and the fragmentation peak at m/z 581 
(Appendix 5.1B) shows a sequential ladder loss of m/z 14 in the region with m/z below 
300, which corresponds to the loss of methyl groups associated with carotenoids.  
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a) 
 
 
b) 
 
Figure 5. 4: ESIMS data of the purified bioactive compounds from in C. raciborskii showing the 
molecular ion peaks and fragmentation peaks: a) Peak 1 with M+ peak of m/z 744.46 and 
fragmentation peak of m/z 581.40 [M-163]+ and b) Peak 2 with M+ peak of m/z 730.48 and 
fragmentation peak of m/z 567.42 [M-163]+. 
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The second bioactive peak (2) that was isolated (tR 8.59 mins) and analyzed using 
the LC-MS (low resolution), showed a m/z of 730.5 for the M+ peak and a m/z of 753.5 
for the [M+Na]+ peak. Analysis using the HRESIMS gave a molecular ion peak of m/z 
730.4801 corresponding to a molecular formula of C46H66O7 with a ring and double bond 
equivalent of 14. A fragmentation peak was identified with a m/z 567.4 [M-163]+ which 
again possibly corresponds to the presence of a methylpentoside. Fragmentation of both 
the molecular ion peak and the fragment peak at m/z 567.4 showed a similar sequential 
loss of m/z 14 (data not shown) to that of 1, which in conjunction with the UV-Vis 
analysis, suggests that these compounds are carotenoids. 
 
 
Peak 1 (m/z 744) 
 
 
Peak 2 (m/z 730) 
 
Figure 5. 5: Structure of 4-ketomyxol 2’-glycoside and myxol 2’-glycoside: the proposed 
compounds for peaks 1 and 2 respectively. 
 
Both compounds are thought to have a glycosidic functional group and based on 
the MS fragmentation (loss of m/z 163) and previously identified glycosidic carotenoids, 
suggest that the glycosidic group could be a methyl pentoside. The glycosidic group of 
previously identified carotenoids with a methyl pentoside have been characterized as a 
rhamnose or fucose, depending on the species from which they were identified (Takaichi 
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et al., 2005). Determination of the glycosidic group for the currently isolated carotenoids 
was not achieved due to the insufficient amounts of sample obtained and the constant 
degradation of the compounds. 
 
5.2.3. Bioactivity of the Carotenoids (Zebrafish Embryo Bioassay) 
  The zebrafish embryo bioassay was used to purify the bioactive compounds from 
C. raciborskii, where a similar bioactivity was observed in the crude extract and each 
subsequent bioactive fraction (Figure 5.6). Embryos were observed at 4dpf at which stage 
normal untreated embryos should have hatched and the development of the body parts 
and body axis is almost complete. Embryos exposed to extracts and fractions were 
observed to not have development of the body axis as well as no distribution of the color, 
with most of the color remaining in the head of the embryos. The embryos also did not 
appear to have differentiation of the various body parts including the eyes, gills, and fins. 
There was no hatching of the embryos up to 5dpf exposed to all treatments. There was 
also no mortality observed as indicated by coagulated embryos however it was difficult to 
ascertain a heartbeat due to the lack of complete development of the organs, especially 
the heart. 
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Figure 5. 6: Bioactivity of the extracts and fractions from C. raciborskii throughout the 
fractionation process, showing the inhibition of development in the zebrafish embryos at 4dpf. A) 
CHCl3 extract at 10µL, B) 10% MeOH fraction from glass column, C) 95% MeOH from RP-18 
SPE cartridge. 
 
  The purified compounds were tested on the zebrafish embryos to confirm their 
bioactivity. Compound 1 was tested at a range of concentrations; 1, 5, 10, 20 and 50 
µg/mL with bioactivity observed only at 20 and 50 µg/mL (Figure 5.7A and B). Embryos 
at the lower concentration (20µg/mL) showed partial development of the body parts such 
as the eyes, however the body axis was slightly shortened and curved and there was 
pericardial edema. At 5dpf, hatching of the embryos (n=5) was at 40% and there was 
20% mortality observed. At the higher concentration (50µg/mL) the embryos showed 
closer resemblance to the crude fractions with little or no differentiation of the eyes and a 
shortened body axis. There was no hatching observed (0% hatching) up to 5dpf and also 
no mortality observed. From the observations of the development of the embryos, it can 
be seen that the higher concentrations showed greater inhibition of development of the 
embryo and their hatching but there were no substantial effects on mortality up to 5dpf. 
Embryos were not observed beyond this stage. For compound 2, the concentration tested 
on the zebrafish embryos was unknown because it was tested directly from the HPLC, 
however similar effects were observed as that of compound 1 at 5dpf (Figure 5.7C).  
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  The presumed decomposed sample of compound 1 was also tested on the zebrafish 
embryos to determine if there was still bioactivity, however the tests were done at 
unknown concentrations (10 and 100µL). No deformities were observed at the lower 
dosage (10µL) but at the higher dosage (100µL), the embryos showed slight deformities 
including bent tails and pericardial edema (Figure 5.7D). Additionally, there seemed to 
be no effect on the hatching of the embryos at both dosages, with 100% hatching 
observed at 5dpf. 
 
 
 
Figure 5. 7: Bioactivity of the purified carotenoids from C. raciborskii showing the inhibition of 
development in the zebrafish embryos at 3dpf. A) Peak 1 at 20µg/mL, B) Peak 1 at 50µg/mL, C) 
Peak 2 (unknown concentration), D) Peak 1 (loss of color; unknown concentration), E) Retinoic 
acid at 10nM, and F) Retinoic acid at 100nM. 
 
Carotenoids undergo oxidative cleavage of the double bonds within the conjugated 
system (See Figure 5.8) to form a class of aldehydes known as apocarotenals, including 
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retinol, retinal, retinoic acid, and derivatives of each, such as 4-ketoretinoids. The most 
well-known apocarotenal is retinal, a 20-C aldehyde which is formed from the cleavage 
of the C15-C15’ double bond (Trautmann et al., 2013). Retinal is then converted to 
retinoic acid in vertebrates by the enzyme retinal dehydrogenases. Retinoic acid acts as a 
signaling molecule (morphogen) that produces specific cellular response based on the 
concentration. These previously mentioned retinoids have been shown to cause 
teratogenic effects in various organisms, including zebrafish embryos (Hermann, 1995), 
mice (Nau, 1990), Xenopus larvae (Durston et al., 1989), and chicken embryo (Thaller 
and Eichele, 1987). Zebrafish embryos were exposed to different concentrations of 
retinoic acid and its analogues at 5 hours post fertilization (5hpf) after which they 
observed various malformations including edema, brain deformities, and shortened and 
bent tails (Herrmann, 1995 and Figure 5.7E and F). These malformations were similar to 
those observed in the embryos exposed to the isolated carotenoids from CAQS (See 
Figure 5.7).  
It can therefore be proposed that the effects observed in the zebrafish embryos after 
exposure to the glycosidic carotenoids could be due to the biotransformation into 
apocarotenals or the corresponding retinoids, which have previously been shown to cause 
malformations in fish and amphibians, and not necessarily the intact carotenoid. 
Provitamin A carotenoids such as β-carotene have been extensively studied and shown to 
undergo oxidative cleavage into retinoic acid and retinal. Non-provitamin A carotenoids 
can also undergo oxidative cleavage into their corresponding retinoids and also other 
metabolites, most of which are currently unknown (Nagao, 2004). Some of these 
metabolites can be further metabolized under oxidative stress for elimination while the 
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retinoid metabolites can interact with the same receptors as retinoic acid (Nagao, 2004; 
Maden, 2002). Retinoids, including retinoic acid, are known to interact with retinoic acid 
receptors (RAR) and retinoid X receptors (RXR) which then homodimerizes, binding to 
the RA-response element (RARE) and subsequently activating the transcription of RA 
target genes (Maden, 2002). Exposure of organisms to exogenous retinoids is known to 
cause various malformations in vertebrates. The biotransformation of carotenoids could 
lead to the increase in the amount of retinoids, which could be the cause of the inhibition 
of development in the zebrafish embryos upon exposure to the carotenoids. A proposed 
mechanism of action of the carotenoids in the zebrafish embryos is therefore via their 
biotransformation into retinoids, causing an increase in the retinoids, which are known 
teratogens. 
 
 
Figure 5. 8: Reaction showing the biotransformation of carotenoids to retinoids by the cleavage of 
the 15-15’ bond through the action of a carotenoid 15,15’-oxygenase to form retinal followed by 
the conversion to retinol or retinoic acid by retinol dehydrogenases (RoDHs) or retinaldehyde 
dehydrogenases (RALDHs) respectively. 
 
Carotenoid 
Retinol              Retinal                Retinoic acid 
Biotransformation 
Carotenoid 15,15’-oxygenase (CO) 
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Furthermore, high incidences of malformations were observed in amphibians, 
predominantly aquatic, from which various factors associated with these deformations 
have been proposed (Gardiner et al., 2003). One such proposed factor is the occurrence 
of teratogenic retinoids produced by cyanobacterial blooms, specifically a Microcystis 
bloom in Lake Taihu, China (Wu et al., 2012 and 2013). Wu et al. (2012 and 2013) 
identified high amounts of retinoids, namely retinoic acid, retinal, and 4-oxo-retinoic 
acid, in the cyanobacterial species found in these lakes. A hypothesis can therefore be 
made that carotenoids can undergo oxidative cleavage to form retinoids which can 
contribute to the teratogenic effects associated with these blooms of cyanobacteria.  
 
5.3. Methods 
5.3.1. Bioassay-Guided Fractionation of the Bioactive Compound 
A bioassay-guided fraction using the zebrafish embryo as the bioassay was 
implemented for the isolation and purification of the bioactive compound from the strain 
of C. raciborskii, C-AQS. The freeze-dried biomass was extracted twice in chloroform in 
a ratio of 10:1 (mg:mL) after which the filtered extract was fractionated by normal-phase 
flash-chromatography on a silica-gel glass column (Silica Gel 60Å, Commercial 40–63 
μm). A stepwise gradient was used of ethyl acetate in hexane and then 10% methanol in 
ethyl acetate. The zebrafish embryo bioassay was used to identify the bioactive fraction 
(10% methanol in ethyl acetate), which was then further fractionated on a reverse-phase 
solid phase extraction (RP-18, SPE) cartridge also with a stepwise gradient of methanol 
in water. The bioactive fraction was observed to be the 95% methanol in water which was 
further separated by reverse-phase HPLC (Phenomenex Luna 5 μm C5 100 Å LC 
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Column 100 × 4.6 mm; isocratic 65:35 acetonitrile/water) with a PDA detector 
(Prominence SPD M20A), wavelength range from 200-700nm). The zebrafish embryo 
bioassay was then used to identify the two bioactive peaks at retention times of 6.68 and 
8.59 minutes.   
 
5.3.2. Characterization of bioactive compounds from C. raciborskii AQS 
The purified compound was chemically characterized by UV-Vis analysis, and 
mass spectrometry (low- and high-resolution). Analyses by mass spectrometry included 
low-resolution analysis on a Thermo TSQ Quantum Access ESI/triple quadrupole 
instrument coupled to a Thermo Accela UHPLC and high-resolution analyses on a 
Thermo Orbitrap. Chemical characterization by NMR included one-dimensional 
experiments (1H) and two-dimensional experiments (homonuclear: COSY) on a Bruker 
AVANCE 400 MHz instrument. 
 
4-ketomyxol 2’-glycoside (1): HRESIMS m/z 744.4548 (C46H64O8, [M]+, mmu of -
2.24); RDB 15; UV/Vis 321, 449sh, 480, and 509 nm; %III/II 12 
 
Myxol 2’-glycoside (2): HRESIMS m/z 730.4801 (C46H66O7, [M]+, mmu of -2.24); 
RDB 14; UV/Vis 295, 368, 450, 478, and 509 nm; %III/II 58. 
 
5.3.3. Zebrafish Embryo Bioassay (Exposure Studies) 
The zebrafish (Danio rerio) embryo was used as a model of developmental 
toxicity for both bioassay-guided fractionation and toxicity studies. Maintenance and 
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breeding of adult zebrafish, and the toxicology studies with the embryos, were carried out 
as previously described by Berry et al. (2007 and 2009) and according to the protocols 
that were approved by the FIU Institutional Animal Care and Use Committee (IACUC). 
All the toxicity studies were done in solvent-resistant, polypropylene 24-well plates 
(Evergreen Scientific, Los Angeles, CA). Exposures were carried out using five embryos 
per well in E3 medium (Brand et al., 2002). Extracts and fractions were typically 
evaluated at a high- (100 μL) and low- (10 μL) exposure concentration; purified 
compound 1 only was evaluated at 2, 5, 10, 20, and 50 μg/mL concentrations (in 
methanol). Retinoic acid (obtained for Sigma Aldrich) was also tested at 10 and 100 nM 
and the bioactivity was compared to that of the carotenoids. Solvent and “untreated” 
controls were included in each assay; the solvent was evaporated from assay plates, prior 
to adding medium and embryos, and accordingly there were no observed effects of the 
solvent (relative to the untreated controls). The embryos were observed up to 5 days post 
fertilization (dpf) for bioactivity which included mortality, inhibition of hatching, and 
inhibition of development. In addition to percent hatching and mortality, developmental 
toxicity was recorded by photomicrography using an Olympus SZX7 stereomicroscope 
equipped with an Olympus DP72 digital camera. 
 
5.4. Conclusion 
The zebrafish embryos were used in the bioassay-guided isolation of two bioactive 
glycosidic carotenoids. The occurrence of carotenoids in cyanobacteria has been well 
documented and there is good evidence to suggest that they play a role in photosynthesis 
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and also in the prevention of photooxidative damage. These identified glycosidic 
carotenoids have been previously identified in other genera of cyanobacteria, including 
Cylindrospermopsis. The sugar moiety of these carotenoids in Anabaena sp. and Nostoc 
punctiforme was identified as fucose and not rhamnose (Takaichi et al., 2005), which 
could be the same for these carotenoids identified from CAQS, however this remains to 
be determined. 
The bioactivities previously observed with these glycosidic carotenoids have been 
related to photoprotection and antioxidant activity (Heydarizadeh et al., 2013). There 
have not been any previous reports which shows these carotenoids to be toxic, however 
from this study, it can be seen that these accessory pigments inhibit the development in 
zebrafish embryos which was used as a model for vertebrate development. It could be 
suggested that the cause of this bioactivity could be due to the decomposition of the 
carotenoids into the corresponding retinoids which have been shown to be teratogenic in 
zebrafish embryos and also amphibians. Further analysis is required to test this 
hypothesis. 
 
References 
1. Berry, J. P.; Gantar, M.; Gibbs, P. D. L.; Schmale, M. C. The zebrafish (Danio rerio) 
embryo as a model system for identification and characterization of developmental 
toxins from marine and freshwater microalgae. Comparative Biochemistry and 
Physiology Part C: Toxicology & Pharmacology 2007, 145, 61-72. 
2. Berry, J. P.; Gibbs, P. D. L.; Schmale, M. C.; Saker, M. L. Toxicity of 
cylindrospermopsin, and other apparent metabolites from Cylindrospermopsis 
raciborskii and Aphanizomenon ovalisporum, to the zebrafish (Danio rerio) embryo. 
Toxicon 2009, 53, 289-299. 
 130 
 
3. Brand, M.; Granato, M.; Nüsslein-Volhard, C. Keeping and Raising Zebrafish. In 
Zebrafish; Nüsslein-Volhard, C., Dahm, R., Eds.; Oxford University Press: Oxford, 
UK, 2002; pp. 7–37. 
4. Britton, G. Structure and properties of carotenoids in relation to function. The FASEB 
Journal 1995, 9, 1551-1558. 
5. Britton, G.; Liaaen-Jensen, S.; Pfander, H. Carotenoids: handbook; Springer: 2004 
6. Durston, A. J.; Timmermanns, J. P. M.; Hage, W. J.; Hendriks, H. F. J.; de Vries, N. 
J.; Heideveld, M.; Nieuwkoop, P. D. Retinoic acid causes an anterior posterior 
transformation in the developing nervous system. Nature 1989, 340, 140-144. 
7. Gardiner, D.; Ndayibagira, A.; Grün, F.; Blumberg, B. Deformed frogs and 
environmental retinoids. Pure and applied chemistry 2003, 75, 2263-2273. 
8. Herrmann, K. Teratogenic effects of retinoic acid and related substances on the early 
development of the zebrafish (Brachydanio rerio) as assessed by a novel scoring 
system. Toxicology in vitro 1995, 9, 267-283. 
9. Heydarizadeh, P.; Poirier, I.; Loizeau, D.; Ulmann, L.; Mimouni, V.; Schoefs, B.; 
Bertrand, M. Plastids of marine phytoplankton produce bioactive pigments and 
lipids. Marine drugs 2013, 11, 3425-3471. 
10. Hirschberg, J.; Chamovitz, D. In Carotenoids in cyanobacteria; The molecular 
biology of cyanobacteria; Springer: 1994; pp 559-579. 
11. Jurgens, U. J.; Weckesser, J. Carotenoid-containing outer membrane of Synechocystis 
sp. strain PCC6714. J. Bacteriol.1985, 164, 384-389. 
12. Maden, M. Retinoid signalling in the development of the central nervous 
system. Nature Reviews Neuroscience 2002, 3, 843-853 
13. Nau, H. Correlation of transplacental and maternal pharmacokinetics of retinoids 
during organogenesis with teratogenicity. Methods in Enzymology 1990, 190(B), 437-
448. 
14. Paerl, H. W. Cyanobacterial carotenoids: their roles in maintaining optimal 
photosynthetic production among aquatic bloom forming genera. Oecologia 1984, 61, 
143-149. 
15. Takaichi, S.; Mochimaru, M. Carotenoids and carotenogenesis in cyanobacteria: 
unique ketocarotenoids and carotenoid glycosides. Cellular and molecular life 
sciences 2007, 64, 2607-2619. 
 131 
 
16. Takaichi, S.; Mochimaru, M.; Maoka, T.; Katoh, H. Myxol and 4-ketomyxol 2′-
fucosides, not rhamnosides, from Anabaena sp. PCC 7120 and Nostoc punctiforme 
PCC 73102, and proposal for the biosynthetic pathway of carotenoids. Plant and cell 
physiology 2005, 46, 497-504. 
17. Takaichi, S.; Shimada, K. Characterization of carotenoids in photosynthetic bacteria. 
Meth. Enzymol. 1992, 213, 374-385. 
18. Thaller, C.; Eichele, G. Identification and spatial distribution of retinoids in the 
developing chick embryo. Nature 1987, 327, 625-628. 
19. Trautmann, D.; Beyer, P.; Al-Babili, S. The ORF slr0091 of Synechocystis sp. 
PCC6803 encodes a high-light induced aldehyde dehydrogenase converting 
apocarotenals and alkanals. FEBS Journal 2013, 280, 3685-3696. 
20. Vermaas, W. F. J.; Timlin, J. A.; Jones, H. D. T.; Sinclair, M. B.; Nieman, L. T.; 
Hamad, S. W.; Melgaard, D. K.; Haaland, D. M. In vivo hyperspectral confocal 
fluorescence imaging to determine pigment localization and distribution in 
cyanobacterial cells. Proceedings of the National Academy of Sciences 2008, 105, 
4050-4055. 
21. Wu, X.; Jiang, J.; Hu, J. Determination and Occurrence of Retinoids in a Eutrophic 
Lake (Taihu Lake, China): Cyanobacteria Blooms Produce Teratogenic Retinal. 
Environ. Sci. Technol. 2013, 47, 807-814. 
22. Wu, X.; Jiang, J.; Wan, Y.; Giesy, J. P.; Hu, J. Cyanobacteria blooms produce 
teratogenic retinoic acids. Proceedings of the National Academy of Sciences 2012, 
109, 9477-9482. 
 132 
 
CHAPTER 6 
 
IDENTIFICATION OF LIPOPHILIC BIOACTIVE FRACTIONS IN THE OTHER 
TOXIGENIC STRAINS OF FRESHWATER CYANOBACTERIA USING THE 
ZEBRAFISH EMBRYO BIOASSAY
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6.1. Introduction 
Cyanobacterial toxins were identified from 2 of the 4 isolates, proposed in this 
project, namely APH and CAQS, however only partial purification was obtained with the 
other two isolates, C. raciborskii 121-1 (denoted CMEX) and M. aeruginosa (denoted 
MC 81-11). This chapter will therefore focus on the identification and partial purification 
of the bioactive compounds/fractions identified from these two isolates.  
M. aeruginosa 81-11 is a great lakes isolate that is known to produce microcystin. 
C. raciborskii 121-1 (Mexico) was isolated from the Lake Catemaco, located in Vera 
Cruz, Mexico where they have been seen to form large blooms year round. The toxins 
CYN and paralytic shellfish toxins (PSTs), known to be produced by the genus 
Cylindrospermopsis, have been shown to be present in this lake (Berry and Lind, 2010). 
This lake represents one of the most productive fisheries in Mexico (Komarkova and 
Tavera, 2003) and other studies have shown that there is bioaccumulation of these toxins 
in tegogolo snails and finfish (Berry et al., 2012). With the importance of this fishery and 
the prevalence of blooms of Cylindrospermopsis, this ecosystem provides a good 
opportunity to study the effects of these known cyanobacterial toxins and unidentified 
toxins on these aquatic species as well as the subsequent effects on human health. 
Even though there were no bioactive compounds isolated from CMEX and MC 81-
11, multiple fractions from these lipophilic extracts showed bioactivity with there being 
some indication to the nature of the compounds in a couple of these fractions. In addition 
to the compounds that have been identified, there still remains many toxic metabolites 
from these cyanoHABs that are unrelated to the known water-soluble toxins that 
contribute to the toxicity of these species. 
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6.2. Results & Discussion  
6.2.1.  Bioactive Fractions from C. raciborskii 121-1 (Mexico) 
The extract was fractionated on a silica-gel glass column using a combination of 
hexane, acetone, and methanol as the eluting solvents. A few sets of bioactive fractions 
were observed from the silica-gel column eluting in 10, 15, 35% acetone in hexane, 
100% acetone, and 100% methanol. The methanol fraction was subsequently analyzed 
because of the observations from the zebrafish bioassay as well as the pigmentation of the 
fraction. 
The chromatogram of the 100% MeOH fraction (Figure 6.1) using the same 
method as with CAQS, showed the bioactive peak (which was the main peak) to have a 
retention time of 4.56 mins, indicating that this compound is slightly more polar than 
those from CAQS. The UV-vis for the bioactive peak (denoted as 3) showed max of 451, 
476, and 507nm with the %III/II of 56. A small sample was analyzed by Dr. Bill Louda 
(Florida Atlantic University; Louda, 2008) with the sample eluting at 11.32 mins. The 
max of the peak was 450, 476, and 508nm with the %III/II of 56. The sample was also 
spiked with different standards of carotenoids (myxoxanthophyll and aphanizophyll; 
obtained from DHI; Denmark) with the aphanizophyll standard eluting at the same 
retention time as the main peak in the sample and having the same UV-vis spectrum 
(Appendix A6.2). This data along with the UV-vis spectrum indicates that the main peak 
is likely to be aphanizophyll (4-hydroxymyxol 2’-glycoside).  
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Figure 6. 1: HPLC Chromatogram of the bioactive fraction indicating the bioactive peak at 
4.56mins with the UV-vis spectrum. 
 
Analysis of the fraction by HR-ESI-MS gave a molecular ion peak of m/z 
746.4762 corresponding to a molecular formula of C46H66O8 with a ring and double bond 
equivalent of 14 (Figure 6.2) . Another peak at m/z 769.5 corresponding to [M+Na]+,was 
observed as well as a fragment ion at m/z 583.4 giving a loss of 163, which is thought to 
be a glycosidic moiety such as a methylpentose as seen in the carotenoids from CAQS. 
MS/MS analysis of the molecular ion gave a series of losses of m/z 14 was observed in 
the region below m/z 200 which again is indicative of the presence of a long alkyl chain 
(Appendix A6.1B).  
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Figure 6. 2: HRESIMS of the bioactive peak with m/z 746.4762 corresponding to M+, 769.4654 
for [M+Na]+, and the fragment ion at m/z 583.4152 [M-163]+, indicative of a loss of a methyl 
glycoside. 
 
 
  Based on the data, the suggested structure of the compound is aphanizophyll 
(Figure 6.3) which was originally identified in the cyanobacteria, Aphanizomenon flos-
aquae. This carotenoid have been previously identified in other strains of cyanobacteria; 
M. aeruginosa, Oscillatoria tenui, Anabaena aerulosa oscillarotiaoides, 
Thermosynechococcus elongatus, and C. raciborskii, however it has not been associated 
with bioactivity (Stransky and Hager, 1970; Iwai et al., 2008; Mehnert et al., 2012). 
Aphanizophyll was originally also called 4-hydroxymyxoxanthophyll (Hertzberg and 
Liaaen-Jensen, 1971) but with later changes of myxoxanthophyll to myxol 2’-glycoside 
(due to the different glycoside moieties present), it is now termed as 4-hydroxymyxol-2’-
glycoside. Further characterization by NMR is required to confirm the identity of this 
compound and to determine the sugar moiety. 
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Figure 6. 3: Structure of 4-hydroxymyxol glycoside (aphanizophyll) identified from the methanol 
fractions of CMEX. 
 
   
Due to the instability of carotenoids, especially during the extraction process (as 
mentioned in Chapter 5), purification of the compound for further structural elucidation 
was not accomplished. However, the above data strongly suggests that the bioactive 
compound associated with this isolate of C. raciborskii is indeed 4-hydroxymyxol 
glycoside. 
 
6.2.2. Bioactive Fractions from M. aeruginosa 
A solvent partitioning in hexane, acetone, and then chloroform showed the hexane 
fraction as the only bioactive fraction and therefore hexane was used for all subsequent 
extractions of the biomass. The hexane fraction was then tested at different doses from 
which a clear dose-dependent relationship was observed (Figure 6.4) with 100% 
mortality being observed at the highest dose (200µL) and inhibition of development at 
sub-lethal doses down to 50µL. There was also a dose-dependent relationship observed 
for the hatching of the embryos with 0% hatching at and above 100µL, 60% hatching at 
50µL and 100% hatching in the controls. The hexane extract was subsequently 
fractionated by two different methods to obtain the bioactive compound/s. 
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Figure 6. 4: Graph showing the percent mortality and hatching of zebrafish embryos exposed to 
different doses of MC 81-11 at 4dpf showing a clear dose-dependent relationship. The bioactivity 
observed at 4dpf with the hexane extract of MC 81-11 at 50µL (A), 100µL (B), and an untreated 
control (C). 
 
Fractionation Method 1: The hexane extract was fractionated on a silica-gel 
column with increasing amounts of ethyl acetate in hexane (5, 10, 15, 20, 25, 30, 35, 40, 
and 50% ethyl acetate in hexane, and 100% ethyl acetate). With this solvent system, there 
was a lot of streaking observed throughout the column and large sets of adjacent fractions 
showed bioactivity suggesting that great separation of the compounds was not obtained. 
The main set of bioactive fractions were collected from 15-30% ethyl acetate in hexane 
and was pooled together for further separation on a prep-TLC. Five bands were observed 
on the TLC with the first three bands showing bioactivity. These three bands were 
subsequently run on the HPLC with fractions collected directly into the 24-well plate for 
the bioassay with the bioactive regions shown in Figure 6.5. From the results of the 
HPLC, there seems to still be overlapping of the bioactive peaks, with the same bioactive 
region being observed in bands 1 and 2 (28-30mins) and also bands 2 and 3 (24-26mins).  
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Figure 6. 5: HPLC Chromatogram of the bioactive regions collected from the TLC. Peaks were 
collected at every 2 minutes in 24-well plates and tested for bioactivity. Bioactive peaks showed 
no distinct UV spectra. 
 
Mass spectral analysis was carried out to identify if the same masses were in the 
different bioactive fractions which would suggested the possibility of the same bioactive 
compound/s in the different bands. Table 6.3 shows the peaks with the same m/z and the 
corresponding retention times. For TLC bands 1 and 2 with the bioactive fraction at 28-
30mins, there were no definitive peaks observed which showed similar masses between 
the two bands. For TLC bands 2 and 3 with the bioactive fraction at 24-26mins there 
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were 3 peaks observed in both fractions which showed the similar masses with similar 
fragmentation patterns, however the retention times were slightly different. The three 
peaks observed had decreasing masses of m/z of 44 with increasing retention times 
suggesting that these compounds may be related. 
 
Table 6. 1: LCMS analysis of the bioactive fraction 24-26mins isolated from the HPLC showing 
the similar m/z peaks observed and the corresponding retention times.  
  Retention 
time /mins m/z 
B
io
ac
tiv
e 
re
gi
on
 
24
-2
6m
in
s 2
nd band 
15.37 493.09 476.91 471.98* 454.91 300.83 
16.23  432.98 427.98* 410.95 256.79 
17.07  388.90* 383.96 366.93 212.84 
   
3rd band 
17.59 492.93 476.96* 471.99 454.89 300.79 
18.45 448.92 432.93* 427.99 410.95 256.80 
19.42 404.87 388.91* 383.95 366.93 212.85 
*base peak 
 
Fractionation Method 2: The hexane extract was fractionated on a silica-gel 
column with increasing amounts of acetone in hexane (5, 10, 15, 20, 30, 40, and 50% 
acetone in hexane, and 100% acetone) followed by a methanol flush. There were 11 
fractions obtained from the silica-gel column of which three showed bioactivity in the 
zebrafish embryos; 5% acetone in hexane, the second fraction from 10% acetone in 
hexane, and 100% acetone. The 5% acetone in hexane fraction was run through another 
silica gel column using hexane and ethyl acetate as the eluting solvents with two bands 
observed using 5% ethyl acetate in hexane with the first band being bioactive. Further 
purification was attempted with TLC and HPLC however there was not enough sample 
remaining for subsequent bioassay-guided purification.  
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Another column was repeated to collect more of the bioactive fraction eluting in 5 
and 10% acetone in hexane. Further fractionation using the HPLC was carried out on 
both fractions where fractions were collected every 2mins and subsequently tested on the 
zebrafish embryos.  
For the 5% acetone fraction, no bioactivity was observed within any of the 
fractions. This could be due to the lipophilic nature of the compound and the bioactive 
compounds were retained on the column with the method used. As such another column 
was used and retested on the zebrafish embryos to identify any bioactive fractions. Figure 
6.6 shows the chromatogram of the 5% acetone fraction indicating the two bioactive 
regions (based on the zebrafish bioassay) and two different wavelengths at which these 
compounds were observed.  
 
Figure 6. 6: HPLC Chromatogram of the 5% acetone in hexane fraction indicating the bioactive 
regions (22-24mins and 26-28mins), observed at two different wavelengths. 
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For the 10% acetone fraction, bioactivity was observed within 20-22mins and 24-
26mins (Figure 6.7), where all the embryos showed 100% mortality at 1dpf.  
 
 
Figure 6. 7: HPLC Chromatogram of the 2nd band in the 10% acetone in hexane bioactive 
fractions at 20-22mins and 24-26mins. 
 
 
6.3.Methods 
6.3.1. Bioactive fractions from C. raciborskii (Mexico) 
Freeze-dried biomass was weighed and extracted in chloroform and sonicated. The 
extract was run through a silica-gel glass column using hexane, acetone, and methanol as 
the eluting solvents using the following solvent system; 10, 15, 20, 25, 30, 35, 40, and 
50% acetone in hexane, 100% acetone, and 100% methanol. The methanol fraction had 
pigments similar to those observed in CAQS and was therefore analyzed for the presence 
of carotenoids using HPLC-PDA and HRESIMS.  
Analysis of the pigments was carried out by William Louda (FAU) according to the 
method by Louda (2008). Separation was done using reverse-phase HPLC using a Waters 
NovaPak 4µ C18 column (3.9 x 150mm) coupled to a photodiode array detector (PDA) 
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for identification of the pigments. The HPLC solvent system implemented involved three 
solvent systems over a 48-minute period as shown in Table 6.4. 
 
Table 6. 2: HPLC-PDA method used to separate and identify the carotenoids present in the 
methanol fraction of CMEX. 
Time (minutes) Solvent “A” Solvent “B” Solvent “C” 
0 60 40 0 
5 60 40 0 
10 0 100 0 
40 0 30 70 
45 0 30 70 
46 0 0 100 
47 0 100 0 
48 60 40 0 
Solvents: A – 0.5M ammonium acetate in methanol/water (85:15, v/v), B – acetonitrile/water 
(90:10, v/v), C – ethyl acetate. 
4-hydroxymyxol glycoside (aphanizophyll): HRESIMS m/z 746.4762 (C46H66O8, [M]+, 
mmu of 0.850) with a ring and double bond equivalent of 14.0.  
 
6.3.2. Purification of Bioactive Compounds from M. aeruginosa 
Fractionation Method 1: The biomass was extracted in chloroform. The extract 
was dried down and solvent partitioned in hexane, acetone, and chloroform. The only 
bioactive fraction was hexane; therefore further extractions were done with hexane. The 
hexane extract was fractionated on a silica-gel glass column with increasing percentages 
of ethyl acetate in hexane (0, 5, 10, 15, 20, 25, 30, 40, 50, 100% ethyl acetate). 
Bioactivity was observed in fractions within the solvent systems 10-30% ethyl acetate in 
hexane. These fractions were then pooled together and a preparative-TLC was done with 
the solvent system of 15% ethyl acetate, 3.75% isopropanol, 81.25% hexane (8.1:1.5:0.4 
- Hexane:Ethyl acetate:Isopropanol). From the preparative-TLC, 8 different regions were 
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collected; 6 distinct bands plus the top and bottom of the TLC plate. Bioactivity was 
observed in bands 1-3 (100% mortality) and 5-6 (all embryos deformed) of the zebrafish 
embryos within 24hpf and as such the first 3 bands were collected and ran through the 
HPLC [Method: Phenomenex Luna 5u C-18 Analytical Column: Acetonitrile and water 
gradient starting with 50% acetonitrile for 5mins then increase to 100% over 20mins, 
kept at 100% acetonitrile for 15mins, then back to 50% acetonitrile over 5mins for a total 
of 40mins]. Fractions were collected from the HPLC at 2 minute increments and the 
bioactive bands observed were analyzed on the LCMS in an attempt to identify masses 
within the fractions. 
 
Fractionation Method 2: This hexane extract was then fractionated using a silica-
gel glass column with increasing amounts of acetone in hexane (0(1), 5(1), 10(2), 15(1), 
20(2), 30(1), 50(1), 100% (1) acetone) then flushed with 100% (1) methanol for a total of 
11 fractions. The 5% acetone in hexane bioactive fraction was solvent partitioned in 
methanol and then hexane, with the methanol fraction showing bioactivity. The methanol 
fraction was further subjected to a lipophilic-sephadex (LH-20) column, using methanol 
as the mobile phase solvent where no further separation was observed. Additional 
purification attempts were carried out to identify the bioactive compound/s using TLC 
and HPLC-UV, however no further bioactivity was observed with the subsequent 
fractionation steps, more likely as a result of insufficient sample. Additional biomass was 
obtained, extracted in hexane, and fractionated as before using the same column with 
hexane and acetone as the eluting solvents. The two bioactive fractions were then run on 
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the HPLC and fractions collected every two minutes in 24-well polypropylene plates to 
test on the zebrafish embryos.  
 
 
6.4.  Conclusion 
The zebrafish embryo model was used as a bioassay to identify bioactive 
compounds within the lipophilic extracts of known toxigenic cyanoHAB species. Two 
sets of bioactive compounds were identified from two of these species (APH and CAQS) 
however there were additional isolates (CMEX and MC 81-11) in which bioactivity was 
observed, however only bioactive fractions containing more than one compounds were 
determined. Progress however was made towards the determination of the bioactive 
metabolite/s from both of these isolates. The isolate CMEX was shown to produce the 
carotenoid, aphanizophyll, a known carotenoid produced by cyanobacteria. This 
carotenoid as with others is associated with photoprotection however crude extracts 
containing aphanizophyll caused developmental malformations in zebrafish embryos. 
The lake in which this isolate of cyanobacteria is found is well known for its fisheries and 
the occurrence of these toxic metabolites may greatly affect the production of some fish 
species. MC 81-11 has also shown various fractions which are bioactive, causing 
mortality as well as inhibition of development in the zebrafish embryos. Further 
purification is needed to identify the bioactive compounds from these fractions. 
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CHAPTER 7 
 
CONCLUSION  
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7.1. Occurrence of Bioactive Lipophilic Secondary Metabolites 
Cyanobacteria are known to produce a wide array of secondary metabolites, which 
when negatively associated with health effects, are termed toxins. It is still unclear the 
purpose of these cyanobacterial toxins, however it is known that there are additional 
bioactive compounds, different from the known cyanotoxins, within the lipophilic 
extracts of these cyanobacterial HABs that contribute to the toxicity of the strains. Within 
this project, we have identified and purified two sets of bioactive compounds, which 
although previously identified, have not been associated with negative health effects. 
Through the use of the zebrafish embryo assay as a model for vertebrate development, we 
were able to identify these compounds as bioactive lipophilic secondary metabolites and 
gain a better understanding of the bioactivity associated with these compounds. 
PMAs have been identified over three decades ago and were identified based on 
their structure. There was no bioactivity observed with the PMAs according to traditional 
bioassays (such as the cytotoxicity assay) with this being the first reported bioactivity 
associated with these compounds. Identified from these strains were six variants of the 
PMAs, differing from each other by the number of methoxy groups present, with the 
methoxy groups ranging from seven to twelve. As previously mentioned, these 
compounds were previously identified in other genera of cyanobacteria suggesting that 
they may be widespread in nature. Analysis of a culture collection provided by Miroslav 
Gantar (FIU, Department of Biological Sciences), indicated that these metabolites are 
relatively widespread and can be found in a number of genera of cyanobacteria belonging 
to different orders, as well as different genera of green algae. The structure of the PMAs 
suggests that the biosynthesis may involve the PKS biosynthetic pathway and based on 
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the feeding experiments done with 13C-labeled acetate, this hypothesis seems to hold true. 
However, NMR analysis indicates that the pattern of incorporation does not follow that of 
a PKS biosynthetic route and suggests that the biosynthesis may occur via a different 
pathway. Evaluation of the bioactivity using the zebrafish embryos indicated a possible 
structure dependence on the bioactivity with the bioactivity decreasing with the 
increasing size of the molecules. This difference in bioactivity could also be related to the 
solubility of the compounds since the medium for the bioassay is water and the PMAs are 
lipophilic. 
Carotenoids were the second set of compounds identified to inhibit the 
development in zebrafish embryos. Characterization by NMR was difficult due to the 
insufficient quantities obtained for each of the compounds as a results of their instability, 
however other tools were used to identify the nature of these compounds. Carotenoids are 
known to be primary metabolites, preventing against photooxidation and aiding in 
photosynthesis. Additionally, they have been largely used as antioxidants in humans and 
other animals. However, the glycosidic carotenoids identified from the two strains of C. 
raciborskii inhibits development of the zebrafish embryos, which is the first report of 
negative effects associated with these compounds. A possible mechanism of bioactivity 
could be the decomposition of the carotenoids to retinoids which have been shown to 
cause malformations in zebrafish embryos, amphibians, and chicks. Further biological 
characterization of these compounds are necessary to identify their mode of action.  
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Table 7. 1: Cyanobacteria and green algae chloroform extracts that were used in the screening 
against the zebrafish embryos, indicating the ones that showed bioactivity by inhibiting their 
development and were also shown to produce PMAs, carotenoids, or both. 
Isolates PMAs Carotenoids 
Cyanobacteria   
*Aphanothece 103-7   
*Aphanizomenon APH  X  
C. raciborskii 121-1  X 
C. raciborskii AQS  X X 
*Microcystis 81-11 X  
Pseudanabaena 108-1 X  
Green Algae   
Chlamydomonas 80-1   
Kirchneriella 104-7   
Scenedesmus 79-1 X  
Scenedesmus 80-15 X  
*Previously identified genera to produce myxoxanthophyll and other currently identified 
bioactive carotenoids. 
 
 
Table 7.1 shows the cyanobacterial and green algal isolates that were shown to 
inhibit development in zebrafish embryos. From the screening of the PMAs, four of the 
cyanobacterial isolates and two of the green algal isolates produced one or more of the 
PMAs identified within this study. Bioactive glycosidic carotenoids were identified in 
two of the cyanobacterial isolates in this study while three of the other genera, namely 
Aphanothece, Aphanizomenon, and Microcystis are known to also produce glycosidic 
carotenoids, specifically myxol 2’-glycoside and 4-ketomyxol 2’-glycoside. The 
bioactivity associated with the lipophilic extracts of these isolates could be related to the 
presence of these bioactive compounds, namely PMAs, carotenoids, or both. There are 
also other compounds, other than the ones identified in this project, within these isolates 
that are responsible for the bioactivity observed which gives rise to the toxicity of the 
strain. 
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In addition to the identified bioactive compounds within this project, there still 
remains a whole suite of toxic secondary metabolites from these cyanoHABs that are 
unrelated to the known water-soluble toxins that may contribute to the toxicity of these 
HAB species. This may pose a great health risk to animals and humans due to the 
frequent occurrence of these cyanoHAB species and the possible bioaccumulation of 
these compounds in the food chain. 
 
7.2. Zebrafish Embryos as a Model for Vertebrate Development 
The zebrafish embryo was used in this project as a model for vertebrate 
development in the identification, purification, and characterization of lipophilic 
secondary metabolites from freshwater isolates of cyanobacterial HABs. The lipophilic 
extracts of these HAB species were previously identified to show that they contained 
bioactive compounds that inhibit the development in zebrafish embryos. Further 
evaluation of these extracts using the zebrafish embryo bioassay to guide the 
fractionation led to the purification of the previously mentioned bioactive compounds. 
Due to the advantages of this model, it allowed for the rapid and high-throughput analysis 
in bioassay-guided purifications of bioactive metabolites from various sources, including 
cyanobacteria. 
The zebrafish embryo has also been well used as a toxicological model in 
evaluating the effects of the known cyanotoxins on the development. We were also able 
to use them in the analysis of the chemically characterized lipophilic metabolites isolated 
from the cyanobacteria to further understand their effects on vertebrate development. The 
zebrafish embryo model has therefore proven to be a well-suited model for the 
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identification of bioactive compounds as well as the study of known and unknown 
cyanobacterial toxins. 
 
7.3. Future Directions 
Cyanobacterial HABs are a continuous problem in today’s environment due to the 
effects of climate change and the eutrophication of the water sources which are 
conducive for the growth and persistence of these blooms. As such, continued research is 
required in the identification of the novel metabolites produced by these blooms that will 
contribute to their toxicity as well as a better understanding for the known metabolites 
produced during these blooms events. This project was able to identify a new set of 
previously identified compounds not associated with bioactivity (PMAs), as well as a set 
of bioactive compounds that have only be associated with its beneficial effects 
(carotenoids). However, we know that there is still a suite of compounds that have not 
been identified as indicated from the bioactive fractions from the other cyanobacterial 
strains (C. raciborskii 121-1 and M. aeruginosa) both of which are highly recognized as 
HABs. Final purification and subsequently chemical characterization is required to 
identify these not yet identified compounds from the aforementioned cyanoHABs, 
especially due to the fact that these genera are recurrent HAB blooms in freshwater 
sources around the world. The Mexico strain of C. raciborskii is in constant bloom and 
therefore provides us with a great opportunity for the study of metabolites from this 
species and the impact the blooms have on the environment, including the aquatic life, 
and human and animal health. 
 153 
 
These cyanoHABs produce a wide variety of compounds with different effects on 
organisms. It is understood how some of these compounds affect the organisms but these 
compounds are not produced individually. As such, it would be interesting to analyze the 
combined effects of these compounds produced by each isolate on the toxicity of 
organisms to assess the possibility of a synergistic effect or maybe even a protective 
effect of one or more of these compounds. This would help to understand the overall 
toxic effects associated with these blooms and not just the effects from the individual 
components, which would allow for better management of water sources during the times 
of these blooms. 
Carotenoids are known for the beneficial impacts in cyanobacteria and in other 
organisms however, we now know that these molecules also have negative impacts, 
inhibiting the development of zebrafish embryos and possible other vertebrate species. It 
would therefore be important to be able to identify the different carotenoids produced by 
the different cyanobacterial species both in culture and in nature, and the bioactivity, if 
any, associated with them. Further investigation is required for the understanding of the 
mechanism of action of these carotenoids and to test the hypothesis of the 
biotransformation of the carotenoids into retinoids, specifically identifying which types 
of retinoids are formed from the different carotenoids. Also, it is known that different 
carotenoids are produced at different temperatures and with the changes in the climate, 
knowledge of the toxicity of the carotenoids produced at different temperatures will also 
help to understand the toxicity of these blooms. 
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APPENDICES 
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A2.1. PMAs Isolated from A. ovalisporum 
A2.1.1. PMA 1 1H-NMR in C6D6 
 
 
 
 
A2.1.2. PMA 2 1H-NMR in C6D6 
 
 
 
 
A2.1.3 - PMA 3 1H-NMR in C6D6 
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A2.1.4. PMA 4 1H-NMR in C6D6 
 
 
 
 
A2.1.5. PMA 5 1H-NMR in C6D6 
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A2.1.6. PMA 6 1H-NMR in C6D6 
 
 
 
 
 
A2.1.7. Blank (NMR tube for PMA 4) 
 
Note: Benzene blank with the same tube used for PMA 4 indicating the presence of 
impurities associated with the NMR tube. 
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A2.2. PMAs Isolated from C. raciborskii 
A2.2.1. PMA 2 1H-NMR in C6D6 
 
 
 
 
A2.2.2. PMA 3 1H-NMR in C6D6 
 
 
 
C – DEPT-135 
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E – HMQC 
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F – HMBC 
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A2.2.3. PMA 4 1H-NMR in C6D6 
 
 
 
 
A2.2.4. PMA 5 1H-NMR in C6D6 
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A2.3. Mass Spectral Data for PMAs from A. ovalisporum  
A2.3.1. MS of PMA 1 
 
 
A2.3.2. MS of PMA 2 
 
 
A2.3.3. MS of PMA 3 
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A2.3.4. MS of PMA 4 
 
 
 
A2.3.5. MS of PMA 5 
 
 
 
A2.3.6. MS of PMA 6 
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A2.4. Cylindro AQS PMAs observed from the HRESIMS 
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A5.1. CAQS Carotenoid 1 (m/z 744) 
A) UV-Vis spectrum from the HPLC-PDA run isocratically at 65% acetonitrile in water. 
 
B) MS/MS of Carotenoid 1 (Molecular ion peak m/z 744) 
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A6.1. CMEX Carotenoid 3 (m/z 746) 
 
A) HPLC-UV/Vis spectrum of the bioactive peak from the 100% MeOH fraction. The 
solvent system used for the HPLC run was 65% acetonitrile in water (isocratic). 
 
 
B) MS/MS of the bioactive peak (m/z 746) 
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A6.2. CMEX (Carotenoid 3; Louda method) 
 
A) Total chromatogram of methanol fraction from CMEX which the proposed 
aphanizophyll peak at 11.32mins circled. 
 
 
 
B) UV-spectrum of the proposed aphanizophyll peak at 11.32mins [UV-vis: 451, 476, 
507nm, %III/II 56] 
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A6.3. MC 81-11 (LC-MS of bioactive fractions from TLC band 2 and 3, 24-26mins) 
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